OA13179A - Novel lincomycin derivatives possessing antimicrobial activity. - Google Patents

Novel lincomycin derivatives possessing antimicrobial activity. Download PDF

Info

Publication number: OA13179A
Authority: OA; OAPI
Prior art keywords: propyl; tetrahydro; pyran; trihydroxy; methylsulfanyl
Prior art date: 2003-06-17

Application number

OA1200500364A

Other languages

English (en)

Inventor

Sampath K Anandan

Mikhail F Gordeev

Jason G Lewis

Hardwin O'dowd

Original Assignee

Vicuron Pharm Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-06-17

Filing date

2004-06-17

Publication date

2006-12-13

2003-08-15 Priority claimed from US10/642,807 external-priority patent/US7164011B2/en

2004-02-11 Priority claimed from US10/777,455 external-priority patent/US7199105B2/en

2004-06-17 Application filed by Vicuron Pharm Inc filed Critical Vicuron Pharm Inc

2006-12-13 Publication of OA13179A publication Critical patent/OA13179A/en

Links

OJMMVQQUTAEWLP-KIDUDLJLSA-N lincomycin Chemical class CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 OJMMVQQUTAEWLP-KIDUDLJLSA-N 0.000 title abstract description 18
230000000845 anti-microbial effect Effects 0.000 title description 4
150000001875 compounds Chemical class 0.000 claims abstract description 177
125000000217 alkyl group Chemical group 0.000 claims description 291
-1 4-pentyl-pyrrolidine-2-carbonyl Chemical group 0.000 claims description 227
229910052739 hydrogen Inorganic materials 0.000 claims description 184
239000001257 hydrogen Substances 0.000 claims description 183
125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 157
125000000547 substituted alkyl group Chemical group 0.000 claims description 126
125000004414 alkyl thio group Chemical group 0.000 claims description 99
125000003342 alkenyl group Chemical group 0.000 claims description 90
125000005843 halogen group Chemical group 0.000 claims description 88
125000001072 heteroaryl group Chemical group 0.000 claims description 87
125000005017 substituted alkenyl group Chemical group 0.000 claims description 76
FYEFLEUMNQBKHG-UHFFFAOYSA-N 2-(1-amino-2-methylpropyl)-6-methylsulfanyloxane-3,4,5-triol Chemical compound CSC1OC(C(N)C(C)C)C(O)C(O)C1O FYEFLEUMNQBKHG-UHFFFAOYSA-N 0.000 claims description 67
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 55
125000003545 alkoxy group Chemical group 0.000 claims description 53
QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 53
IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 52
125000003118 aryl group Chemical group 0.000 claims description 47
125000000623 heterocyclic group Chemical group 0.000 claims description 45
125000005415 substituted alkoxy group Chemical group 0.000 claims description 44
239000002253 acid Substances 0.000 claims description 42
229910052757 nitrogen Inorganic materials 0.000 claims description 42
229910052760 oxygen Inorganic materials 0.000 claims description 41
239000001301 oxygen Substances 0.000 claims description 40
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 36
125000003107 substituted aryl group Chemical group 0.000 claims description 36
150000003839 salts Chemical class 0.000 claims description 35
125000004093 cyano group Chemical group *C#N 0.000 claims description 33
239000000651 prodrug Substances 0.000 claims description 32
229940002612 prodrug Drugs 0.000 claims description 32
125000000753 cycloalkyl group Chemical group 0.000 claims description 30
125000001424 substituent group Chemical group 0.000 claims description 30
150000001412 amines Chemical class 0.000 claims description 28
150000002148 esters Chemical class 0.000 claims description 26
125000004356 hydroxy functional group Chemical group O* 0.000 claims description 26
150000002829 nitrogen Chemical class 0.000 claims description 26
150000002926 oxygen Chemical class 0.000 claims description 26
239000008194 pharmaceutical composition Substances 0.000 claims description 26
125000002768 hydroxyalkyl group Chemical group 0.000 claims description 25
125000001316 cycloalkyl alkyl group Chemical group 0.000 claims description 23
241000124008 Mammalia Species 0.000 claims description 22
125000000304 alkynyl group Chemical group 0.000 claims description 22
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 22
208000015181 infectious disease Diseases 0.000 claims description 21
229910052736 halogen Inorganic materials 0.000 claims description 20
125000005346 substituted cycloalkyl group Chemical group 0.000 claims description 20
150000002367 halogens Chemical class 0.000 claims description 19
125000004187 tetrahydropyran-2-yl group Chemical group [H]C1([H])OC([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 17
TVVQUVMUAMNLLX-UHFFFAOYSA-N 2-(1-amino-2-chloropropyl)-6-methylsulfanyloxane-3,4,5-triol Chemical compound CSC1OC(C(N)C(C)Cl)C(O)C(O)C1O TVVQUVMUAMNLLX-UHFFFAOYSA-N 0.000 claims description 16
229910020008 S(O) Inorganic materials 0.000 claims description 16
125000005083 alkoxyalkoxy group Chemical group 0.000 claims description 16
150000001409 amidines Chemical class 0.000 claims description 16
239000012634 fragment Substances 0.000 claims description 16
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 14
239000003814 drug Substances 0.000 claims description 14
OSFBJERFMQCEQY-UHFFFAOYSA-N propylidene Chemical group [CH]CC OSFBJERFMQCEQY-UHFFFAOYSA-N 0.000 claims description 14
238000011282 treatment Methods 0.000 claims description 14
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 13
125000004426 substituted alkynyl group Chemical group 0.000 claims description 13
229910052717 sulfur Inorganic materials 0.000 claims description 13
239000011593 sulfur Substances 0.000 claims description 13
RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 claims description 12
125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 12
125000004001 thioalkyl group Chemical group 0.000 claims description 12
QSWMXBBKOQVGOX-UHFFFAOYSA-N 4-fluoro-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-propylpyrrolidine-2-carboxamide Chemical compound C1C(CCC)(F)CNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC)O1 QSWMXBBKOQVGOX-UHFFFAOYSA-N 0.000 claims description 10
241000606768 Haemophilus influenzae Species 0.000 claims description 10
125000001153 fluoro group Chemical group F* 0.000 claims description 10
230000000813 microbial effect Effects 0.000 claims description 10
239000003937 drug carrier Substances 0.000 claims description 9
229940047650 haemophilus influenzae Drugs 0.000 claims description 9
125000001188 haloalkyl group Chemical group 0.000 claims description 9
KOGLZVRPQJRCHE-UHFFFAOYSA-N phenyl 2-[[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]carbamoyl]-4-propylpiperidine-1-carboxylate Chemical compound C1C(CCC)CCN(C(=O)OC=2C=CC=CC=2)C1C(=O)NC(C(C)C)C1OC(SC)C(O)C(O)C1O KOGLZVRPQJRCHE-UHFFFAOYSA-N 0.000 claims description 9
DNSDOTXFVIOTHM-UHFFFAOYSA-N 4-(3-imidazol-1-ylpropyl)-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]piperidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)C)NC(=O)C1NCCC(CCCN2C=NC=C2)C1 DNSDOTXFVIOTHM-UHFFFAOYSA-N 0.000 claims description 8
229910003827 NRaRb Inorganic materials 0.000 claims description 8
125000004005 formimidoyl group Chemical group [H]\N=C(/[H])* 0.000 claims description 8
230000005764 inhibitory process Effects 0.000 claims description 8
AEEIMWYSDWZKAT-UHFFFAOYSA-N 2-(1-amino-2-hydroxypropyl)-6-methylsulfanyloxane-3,4,5-triol Chemical compound CSC1OC(C(N)C(C)O)C(O)C(O)C1O AEEIMWYSDWZKAT-UHFFFAOYSA-N 0.000 claims description 7
241000194031 Enterococcus faecium Species 0.000 claims description 7
AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 claims description 7
125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 claims description 7
230000037396 body weight Effects 0.000 claims description 7
125000005518 carboxamido group Chemical group 0.000 claims description 7
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 7
125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims description 6
UUHWQBMPDDOBFD-UHFFFAOYSA-N 4-[(2,4-dichlorophenyl)methylsulfanyl]-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]pyrrolidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)C)NC(=O)C1NCC(SCC=2C(=CC(Cl)=CC=2)Cl)C1 UUHWQBMPDDOBFD-UHFFFAOYSA-N 0.000 claims description 6
241000194032 Enterococcus faecalis Species 0.000 claims description 6
241000588655 Moraxella catarrhalis Species 0.000 claims description 6
125000004423 acyloxy group Chemical group 0.000 claims description 6
125000005163 aryl sulfanyl group Chemical group 0.000 claims description 6
125000004966 cyanoalkyl group Chemical group 0.000 claims description 6
IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 6
FPMGQPCEYFNJEM-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-fluoro-4-propylpyrrolidine-2-carboxamide Chemical compound C1C(CCC)(F)CNC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(O)C(SC)O1 FPMGQPCEYFNJEM-UHFFFAOYSA-N 0.000 claims description 6
150000003141 primary amines Chemical class 0.000 claims description 6
125000002924 primary amino group Chemical class [H]N([H])* 0.000 claims description 6
229910052705 radium Inorganic materials 0.000 claims description 6
229910052701 rubidium Inorganic materials 0.000 claims description 6
XIMHZYAPAGVPED-UHFFFAOYSA-N 4-(3-ethoxyiminopropyl)-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]piperidine-2-carboxamide Chemical compound C1C(CCC=NOCC)CCNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC)O1 XIMHZYAPAGVPED-UHFFFAOYSA-N 0.000 claims description 5
SQKDXZQUEXTRJB-UHFFFAOYSA-N 4-[3-(difluoromethylsulfanyl)propyl]-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]piperidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)C)NC(=O)C1NCCC(CCCSC(F)F)C1 SQKDXZQUEXTRJB-UHFFFAOYSA-N 0.000 claims description 5
KJQAZPSDPJLGHW-UHFFFAOYSA-N 4-fluoro-n-[2-hydroxy-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-propylpyrrolidine-2-carboxamide Chemical compound C1C(CCC)(F)CNC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 KJQAZPSDPJLGHW-UHFFFAOYSA-N 0.000 claims description 5
MWFXOTFLZLDBEM-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-fluoro-4-propylpiperidine-2-carboxamide Chemical compound C1C(CCC)(F)CCNC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(O)C(SC)O1 MWFXOTFLZLDBEM-UHFFFAOYSA-N 0.000 claims description 5
HMSWIFDRIQNBGG-UHFFFAOYSA-N 2-(1-amino-2-methylpropyl)-6-propyloxane-3,4,5-triol Chemical compound CCCC1OC(C(N)C(C)C)C(O)C(O)C1O HMSWIFDRIQNBGG-UHFFFAOYSA-N 0.000 claims description 4
ZOGNUIUCLMYNTO-UHFFFAOYSA-N 4-propylpiperidine-2-carboxylic acid Chemical compound CCCC1CCNC(C(O)=O)C1 ZOGNUIUCLMYNTO-UHFFFAOYSA-N 0.000 claims description 4
241000606124 Bacteroides fragilis Species 0.000 claims description 4
241000606123 Bacteroides thetaiotaomicron Species 0.000 claims description 4
241000193163 Clostridioides difficile Species 0.000 claims description 4
241000588724 Escherichia coli Species 0.000 claims description 4
241000191967 Staphylococcus aureus Species 0.000 claims description 4
241000193998 Streptococcus pneumoniae Species 0.000 claims description 4
229940032049 enterococcus faecalis Drugs 0.000 claims description 4
125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 claims description 4
JEWPVRAVLNZTFI-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-[3-(difluoromethylsulfanyl)propyl]piperidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)Cl)NC(=O)C1NCCC(CCCSC(F)F)C1 JEWPVRAVLNZTFI-UHFFFAOYSA-N 0.000 claims description 4
WMLLIPGOPKGHDP-UHFFFAOYSA-N n-[2-hydroxy-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-[(4-methylphenyl)methylsulfanyl]pyrrolidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)O)NC(=O)C1NCC(SCC=2C=CC(C)=CC=2)C1 WMLLIPGOPKGHDP-UHFFFAOYSA-N 0.000 claims description 4
HETSCOAYMHOHEH-UHFFFAOYSA-N n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-propylidenepiperidine-2-carboxamide Chemical compound C1C(=CCC)CCNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC)O1 HETSCOAYMHOHEH-UHFFFAOYSA-N 0.000 claims description 4
229940031000 streptococcus pneumoniae Drugs 0.000 claims description 4
YXTGYVVINPIWMF-UHFFFAOYSA-N 1-(1h-imidazol-2-ylmethyl)-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-pentylpyrrolidine-2-carboxamide Chemical compound C1C(CCCCC)CC(C(=O)NC(C(C)C)C2C(C(O)C(O)C(SC)O2)O)N1CC1=NC=CN1 YXTGYVVINPIWMF-UHFFFAOYSA-N 0.000 claims description 3
MFRNJOFFXJVNGY-UHFFFAOYSA-N 1-(2-amino-2-oxoethyl)-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-pentylpyrrolidine-2-carboxamide Chemical compound NC(=O)CN1CC(CCCCC)CC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC)O1 MFRNJOFFXJVNGY-UHFFFAOYSA-N 0.000 claims description 3
CVIFYQUYQFXVDZ-UHFFFAOYSA-N 1-(2-aminoethyl)-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-pentylpyrrolidine-2-carboxamide Chemical compound NCCN1CC(CCCCC)CC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC)O1 CVIFYQUYQFXVDZ-UHFFFAOYSA-N 0.000 claims description 3
ORHUTNZUHATDOA-UHFFFAOYSA-N 4-(3-cyanopropyl)-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]piperidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)C)NC(=O)C1NCCC(CCCC#N)C1 ORHUTNZUHATDOA-UHFFFAOYSA-N 0.000 claims description 3
DFFGSIHJPZINEB-UHFFFAOYSA-N 4-(3-methoxyiminopropyl)-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]piperidine-2-carboxamide Chemical compound C1C(CCC=NOC)CCNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC)O1 DFFGSIHJPZINEB-UHFFFAOYSA-N 0.000 claims description 3
XFNUUYSUWJWLNT-UHFFFAOYSA-N 4-(4-fluorophenyl)sulfanyl-n-[2-hydroxy-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]pyrrolidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)O)NC(=O)C1NCC(SC=2C=CC(F)=CC=2)C1 XFNUUYSUWJWLNT-UHFFFAOYSA-N 0.000 claims description 3
LENXSCSKTOFZOG-UHFFFAOYSA-N 4-[(4-fluorophenyl)methylsulfanyl]-n-[2-hydroxy-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]pyrrolidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)O)NC(=O)C1NCC(SCC=2C=CC(F)=CC=2)C1 LENXSCSKTOFZOG-UHFFFAOYSA-N 0.000 claims description 3
VMVKTZMYJAAJIR-UHFFFAOYSA-N 4-[2-(1,3-dithiolan-2-yl)ethyl]-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]piperidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)C)NC(=O)C1NCCC(CCC2SCCS2)C1 VMVKTZMYJAAJIR-UHFFFAOYSA-N 0.000 claims description 3
OZBVXYHTCGJFOZ-UHFFFAOYSA-N 4-[2-(4-methyl-1,3-thiazol-2-yl)ethyl]-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]piperidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)C)NC(=O)C1NCCC(CCC=2SC=C(C)N=2)C1 OZBVXYHTCGJFOZ-UHFFFAOYSA-N 0.000 claims description 3
FWKVABSODRWXDO-UHFFFAOYSA-N 4-butyl-1-methyl-n-[2-methyl-1-(3,4,5-trihydroxy-6-propyloxan-2-yl)propyl]pyrrolidine-2-carboxamide Chemical compound CN1CC(CCCC)CC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(CCC)O1 FWKVABSODRWXDO-UHFFFAOYSA-N 0.000 claims description 3
RIBVZRFRMBNDEX-UHFFFAOYSA-N 4-ethylsulfanyl-n-[2-hydroxy-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]pyrrolidine-2-carboxamide Chemical compound C1C(SCC)CNC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 RIBVZRFRMBNDEX-UHFFFAOYSA-N 0.000 claims description 3
NJIGWPJQQDNCKQ-UHFFFAOYSA-N 4-fluoro-4-propylpyrrolidine-2-carboxylic acid Chemical compound CCCC1(F)CNC(C(O)=O)C1 NJIGWPJQQDNCKQ-UHFFFAOYSA-N 0.000 claims description 3
235000021314 Palmitic acid Nutrition 0.000 claims description 3
IBWQQAGVOVLECJ-UHFFFAOYSA-N [4,5-dihydroxy-6-[2-methyl-1-[(4-propylpyrrolidine-2-carbonyl)amino]propyl]-2-propyloxan-3-yl] hexadecanoate Chemical compound OC1C(O)C(OC(=O)CCCCCCCCCCCCCCC)C(CCC)OC1C(C(C)C)NC(=O)C1NCC(CCC)C1 IBWQQAGVOVLECJ-UHFFFAOYSA-N 0.000 claims description 3
GCBGCRVFIGNWLR-UHFFFAOYSA-N n-[2-hydroxy-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-(pyrazin-2-ylmethylsulfanyl)pyrrolidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)O)NC(=O)C1NCC(SCC=2N=CC=NC=2)C1 GCBGCRVFIGNWLR-UHFFFAOYSA-N 0.000 claims description 3
JYWRNFNQNIZOEQ-UHFFFAOYSA-N n-[2-hydroxy-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-(thiophen-2-ylmethylsulfanyl)pyrrolidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)O)NC(=O)C1NCC(SCC=2SC=CC=2)C1 JYWRNFNQNIZOEQ-UHFFFAOYSA-N 0.000 claims description 3
NSKMMGDLZOZZNL-UHFFFAOYSA-N n-[2-methyl-1-(3,4,5-trihydroxy-6-propyloxan-2-yl)propyl]-4-propylpiperidine-2-carboxamide Chemical compound C1C(CCC)CCNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(CCC)O1 NSKMMGDLZOZZNL-UHFFFAOYSA-N 0.000 claims description 3
LMWCAOHYAYDOSH-UHFFFAOYSA-N n-[2-methyl-1-(3,4,5-trihydroxyoxan-2-yl)propyl]-4-pentylpyrrolidine-2-carboxamide Chemical compound C1C(CCCCC)CNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)CO1 LMWCAOHYAYDOSH-UHFFFAOYSA-N 0.000 claims description 3
FRPCTAZJHCODMF-UHFFFAOYSA-N n-[2-methyl-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]propyl]-4-propylpyrrolidine-2-carboxamide Chemical compound C1C(CCC)CNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(CO)O1 FRPCTAZJHCODMF-UHFFFAOYSA-N 0.000 claims description 3
KAJCUQFVHXVSBW-UHFFFAOYSA-N 1-(2-formamidoethyl)-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-pentylpyrrolidine-2-carboxamide Chemical compound O=CNCCN1CC(CCCCC)CC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC)O1 KAJCUQFVHXVSBW-UHFFFAOYSA-N 0.000 claims description 2
FQBCBGDNIAEUOW-UHFFFAOYSA-N 2-[[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]carbamoyl]-4-fluoro-4-propylpiperidine-1-carboxylic acid Chemical compound C1C(CCC)(F)CCN(C(O)=O)C1C(=O)NC(C(C)Cl)C1C(O)C(O)C(O)C(SC)O1 FQBCBGDNIAEUOW-UHFFFAOYSA-N 0.000 claims description 2
FLOCIAVGIOZWEB-UHFFFAOYSA-N 2-[[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]carbamoyl]-5-propylazepane-1-carboxylic acid Chemical compound OC(=O)N1CCC(CCC)CCC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(O)C(SC)O1 FLOCIAVGIOZWEB-UHFFFAOYSA-N 0.000 claims description 2
KIEQCVIQWZRPGB-UHFFFAOYSA-N 4-(3-pyridin-4-ylpropyl)pyrrolidine-2-carboxylic acid Chemical compound C1NC(C(=O)O)CC1CCCC1=CC=NC=C1 KIEQCVIQWZRPGB-UHFFFAOYSA-N 0.000 claims description 2
NKXGEEURCBYMOZ-UHFFFAOYSA-N 4-[(4-methylphenyl)methylsulfanyl]pyrrolidine-2-carboxylic acid Chemical compound C1=CC(C)=CC=C1CSC1CC(C(O)=O)NC1 NKXGEEURCBYMOZ-UHFFFAOYSA-N 0.000 claims description 2
YDLWJBLUPXZDMU-UHFFFAOYSA-N 4-[3-(2-oxopyrrolidin-1-yl)propyl]piperidine-2-carboxylic acid Chemical compound C1CNC(C(=O)O)CC1CCCN1C(=O)CCC1 YDLWJBLUPXZDMU-UHFFFAOYSA-N 0.000 claims description 2
HXWYQIJZYOXRLX-UHFFFAOYSA-N 4-[3-(difluoromethylsulfanyl)propyl]piperidine-2-carboxylic acid Chemical compound OC(=O)C1CC(CCCSC(F)F)CCN1 HXWYQIJZYOXRLX-UHFFFAOYSA-N 0.000 claims description 2
RIARHRRVRFDSBD-UHFFFAOYSA-N 4-butylsulfanyl-n-[2-hydroxy-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]pyrrolidine-2-carboxamide Chemical compound C1C(SCCCC)CNC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 RIARHRRVRFDSBD-UHFFFAOYSA-N 0.000 claims description 2
YTWSNEQETWKOEE-UHFFFAOYSA-N 4-butylsulfanylpyrrolidine-2-carboxylic acid Chemical compound CCCCSC1CNC(C(O)=O)C1 YTWSNEQETWKOEE-UHFFFAOYSA-N 0.000 claims description 2
DQHUOKOFSXEEAW-UHFFFAOYSA-N 4-propylpyrrolidin-1-ium-2-carboxylate Chemical compound CCCC1CNC(C(O)=O)C1 DQHUOKOFSXEEAW-UHFFFAOYSA-N 0.000 claims description 2
PJAIRCFEKPCWHY-UHFFFAOYSA-N [6-[2-chloro-1-[(4-fluoro-4-propylpiperidine-2-carbonyl)amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate Chemical compound C1C(CCC)(F)CCNC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(OP(O)(O)=O)C(SC)O1 PJAIRCFEKPCWHY-UHFFFAOYSA-N 0.000 claims description 2
KZCMXQCUJQVHEX-UHFFFAOYSA-N [6-[2-chloro-1-[(4-fluoro-4-propylpiperidine-2-carbonyl)amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] hexadecanoate Chemical compound O1C(SC)C(OC(=O)CCCCCCCCCCCCCCC)C(O)C(O)C1C(C(C)Cl)NC(=O)C1NCCC(F)(CCC)C1 KZCMXQCUJQVHEX-UHFFFAOYSA-N 0.000 claims description 2
WXMKEDHDRCJXMX-UHFFFAOYSA-N [6-[2-chloro-1-[(5-fluoro-5-propylazepane-2-carbonyl)amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate Chemical compound C1CC(CCC)(F)CCNC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(OP(O)(O)=O)C(SC)O1 WXMKEDHDRCJXMX-UHFFFAOYSA-N 0.000 claims description 2
KLKVEPCCSKYZHJ-UHFFFAOYSA-N [6-[2-chloro-1-[(5-propylazepane-2-carbonyl)amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] hexadecanoate Chemical compound O1C(SC)C(OC(=O)CCCCCCCCCCCCCCC)C(O)C(O)C1C(C(C)Cl)NC(=O)C1NCCC(CCC)CC1 KLKVEPCCSKYZHJ-UHFFFAOYSA-N 0.000 claims description 2
SWLXTVSLIMVWFW-UHFFFAOYSA-N [6-[2-chloro-1-[[5-(cyclopropylmethyl)azepane-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate Chemical compound OC1C(O)C(OP(O)(O)=O)C(SC)OC1C(C(C)Cl)NC(=O)C1NCCC(CC2CC2)CC1 SWLXTVSLIMVWFW-UHFFFAOYSA-N 0.000 claims description 2
HCFRXDXGDYLNKB-UHFFFAOYSA-N n-[1-[6-(cyclopropylmethyl)-3,4,5-trihydroxyoxan-2-yl]-2-methylpropyl]-4-propylpyrrolidine-2-carboxamide Chemical compound C1C(CCC)CNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(CC2CC2)O1 HCFRXDXGDYLNKB-UHFFFAOYSA-N 0.000 claims description 2
LOTXOLDKOMAKAY-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-ethylsulfanylpyrrolidine-2-carboxamide Chemical compound C1C(SCC)CNC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(O)C(SC)O1 LOTXOLDKOMAKAY-UHFFFAOYSA-N 0.000 claims description 2
DZWARKMMNMLORV-UHFFFAOYSA-N n-[2-hydroxy-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-(3,3,3-trifluoropropylsulfanyl)pyrrolidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)O)NC(=O)C1NCC(SCCC(F)(F)F)C1 DZWARKMMNMLORV-UHFFFAOYSA-N 0.000 claims description 2
YQRAVPQGKCBDCK-UHFFFAOYSA-N n-[2-hydroxy-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-(3-methylbutylsulfanyl)pyrrolidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)O)NC(=O)C1NCC(SCCC(C)C)C1 YQRAVPQGKCBDCK-UHFFFAOYSA-N 0.000 claims description 2
BQABFQXRHPUTGW-UHFFFAOYSA-N n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-(3-pyridin-4-ylpropyl)pyrrolidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)C)NC(=O)C1NCC(CCCC=2C=CN=CC=2)C1 BQABFQXRHPUTGW-UHFFFAOYSA-N 0.000 claims description 2
ADZCSXXLFDMSBV-UHFFFAOYSA-N n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-[2-(triazol-1-yl)ethyl]piperidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)C)NC(=O)C1NCCC(CCN2N=NC=C2)C1 ADZCSXXLFDMSBV-UHFFFAOYSA-N 0.000 claims description 2
SZOJVKWLQWSYCL-UHFFFAOYSA-N n-[2-methyl-1-(3,4,5-trihydroxy-6-propyloxan-2-yl)propyl]-4-pentylpyrrolidine-2-carboxamide Chemical compound C1C(CCCCC)CNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(CCC)O1 SZOJVKWLQWSYCL-UHFFFAOYSA-N 0.000 claims description 2
YKTCRJMDZJEYIR-UHFFFAOYSA-N n-[2-methyl-1-[3,4,5-trihydroxy-6-(2-methylsulfanylethyl)oxan-2-yl]propyl]-4-propylpyrrolidine-2-carboxamide Chemical compound C1C(CCC)CNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(CCSC)O1 YKTCRJMDZJEYIR-UHFFFAOYSA-N 0.000 claims description 2
WRCFHQGUCJQRQD-UHFFFAOYSA-N n-[2-methyl-1-[3,4,5-trihydroxy-6-(3-hydroxypropyl)oxan-2-yl]propyl]-4-propylpyrrolidine-2-carboxamide Chemical compound C1C(CCC)CNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(CCCO)O1 WRCFHQGUCJQRQD-UHFFFAOYSA-N 0.000 claims description 2
DLFVBJFMPXGRIB-UHFFFAOYSA-N thioacetamide Natural products CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims 17
125000004485 2-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])C1([H])* 0.000 claims 10
125000004453 alkoxycarbonyl group Chemical group 0.000 claims 8
YXHXKZBXKLKBML-UHFFFAOYSA-N 4-(3-ethylsulfanylpropyl)-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]piperidine-2-carboxamide Chemical compound C1C(CCCSCC)CCNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC)O1 YXHXKZBXKLKBML-UHFFFAOYSA-N 0.000 claims 4
CVROZZFVFAXTKC-UHFFFAOYSA-N 4-[2-(4-ethyl-1,3-thiazol-2-yl)ethyl]-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]piperidine-2-carboxamide Chemical compound CCC1=CSC(CCC2CC(NCC2)C(=O)NC(C(C)C)C2C(C(O)C(O)C(SC)O2)O)=N1 CVROZZFVFAXTKC-UHFFFAOYSA-N 0.000 claims 4
MKTSNRNWQWWNBS-UHFFFAOYSA-N 4-fluoro-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-propylpiperidine-2-carboxamide Chemical compound C1C(CCC)(F)CCNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC)O1 MKTSNRNWQWWNBS-UHFFFAOYSA-N 0.000 claims 4
125000004466 alkoxycarbonylamino group Chemical group 0.000 claims 4
238000004519 manufacturing process Methods 0.000 claims 4
UMLHDABYMANNEV-UHFFFAOYSA-N 1-(2-methoxyethyl)-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-pentylpyrrolidine-2-carboxamide Chemical compound COCCN1CC(CCCCC)CC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC)O1 UMLHDABYMANNEV-UHFFFAOYSA-N 0.000 claims 3
BERAAJKLZUCLOQ-UHFFFAOYSA-N 1-methanimidoyl-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-pentylpyrrolidine-2-carboxamide Chemical compound N=CN1CC(CCCCC)CC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC)O1 BERAAJKLZUCLOQ-UHFFFAOYSA-N 0.000 claims 3
ZLAXTLUWJXUNMJ-UHFFFAOYSA-N 4-butylsulfanyl-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]pyrrolidine-2-carboxamide Chemical compound C1C(SCCCC)CNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC)O1 ZLAXTLUWJXUNMJ-UHFFFAOYSA-N 0.000 claims 3
UZRDREPVAWXHDU-UHFFFAOYSA-N ethyl 2-[[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]carbamoyl]-4-propylpiperidine-1-carboxylate Chemical compound C1C(CCC)CCN(C(=O)OCC)C1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC)O1 UZRDREPVAWXHDU-UHFFFAOYSA-N 0.000 claims 3
QJGYZJVCWOMBJW-UHFFFAOYSA-N methyl 2-[2-[[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]carbamoyl]-4-pentylpyrrolidin-1-yl]acetate Chemical compound COC(=O)CN1CC(CCCCC)CC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC)O1 QJGYZJVCWOMBJW-UHFFFAOYSA-N 0.000 claims 3
NBTVKZAHDVVTCW-UHFFFAOYSA-N n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-(pyrrol-1-ylmethyl)piperidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)C)NC(=O)C1NCCC(CN2C=CC=C2)C1 NBTVKZAHDVVTCW-UHFFFAOYSA-N 0.000 claims 3
HARUDSUZZMKALL-UHFFFAOYSA-N 1-(cyanomethyl)-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-pentylpyrrolidine-2-carboxamide Chemical compound N#CCN1CC(CCCCC)CC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC)O1 HARUDSUZZMKALL-UHFFFAOYSA-N 0.000 claims 2
JAGZVFIOIJHOFQ-UHFFFAOYSA-N 2-[[2-methyl-1-(3,4,5-trihydroxy-6-propyloxan-2-yl)propyl]carbamoyl]-4-pentylpyrrolidine-1-carboxylic acid Chemical compound OC(=O)N1CC(CCCCC)CC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(CCC)O1 JAGZVFIOIJHOFQ-UHFFFAOYSA-N 0.000 claims 2
ORFBIJWBRZFLCN-UHFFFAOYSA-N 2-[[2-methyl-1-(3,4,5-trihydroxy-6-propyloxan-2-yl)propyl]carbamoyl]-4-propylpyrrolidine-1-carboxylic acid Chemical compound OC(=O)N1CC(CCC)CC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(CCC)O1 ORFBIJWBRZFLCN-UHFFFAOYSA-N 0.000 claims 2
LQWDJYFRULESRD-UHFFFAOYSA-N 4-(pyridin-2-ylmethylsulfanyl)pyrrolidine-2-carboxylic acid Chemical compound C1NC(C(=O)O)CC1SCC1=CC=CC=N1 LQWDJYFRULESRD-UHFFFAOYSA-N 0.000 claims 2
JNBJRGXYGPSWLD-UHFFFAOYSA-N 4-[(3-methylphenyl)methylsulfanyl]pyrrolidine-2-carboxylic acid Chemical compound CC1=CC=CC(CSC2CC(NC2)C(O)=O)=C1 JNBJRGXYGPSWLD-UHFFFAOYSA-N 0.000 claims 2
FVOOQCWRMPHUEZ-UHFFFAOYSA-N 4-[(4-fluorophenyl)methylsulfanyl]pyrrolidin-1-ium-2-carboxylate Chemical compound C1NC(C(=O)O)CC1SCC1=CC=C(F)C=C1 FVOOQCWRMPHUEZ-UHFFFAOYSA-N 0.000 claims 2
HDINUXUNJMXPJX-UHFFFAOYSA-N 4-[3-(furan-2-ylmethylsulfanyl)propyl]-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]piperidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)C)NC(=O)C1NCCC(CCCSCC=2OC=CC=2)C1 HDINUXUNJMXPJX-UHFFFAOYSA-N 0.000 claims 2
SFAPNAFXCFKSJI-UHFFFAOYSA-N n-[1-(6-butoxy-3,4,5-trihydroxyoxan-2-yl)-2-methylpropyl]-4-pentylpyrrolidine-2-carboxamide Chemical compound C1C(CCCCC)CNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(OCCCC)O1 SFAPNAFXCFKSJI-UHFFFAOYSA-N 0.000 claims 2
DVCMRITUTVVRFF-UHFFFAOYSA-N n-[2-hydroxy-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-[2-(2-sulfanylethoxy)ethylsulfanyl]pyrrolidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)O)NC(=O)C1NCC(SCCOCCS)C1 DVCMRITUTVVRFF-UHFFFAOYSA-N 0.000 claims 2
OLRKOHTWARFZBA-UHFFFAOYSA-N n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-(3-thiophen-2-ylsulfanylpropyl)piperidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)C)NC(=O)C1NCCC(CCCSC=2SC=CC=2)C1 OLRKOHTWARFZBA-UHFFFAOYSA-N 0.000 claims 2
PTBVYWPTUFDVAQ-UHFFFAOYSA-N n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-[3-(2-oxopyrrolidin-1-yl)propyl]piperidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)C)NC(=O)C1NCCC(CCCN2C(CCC2)=O)C1 PTBVYWPTUFDVAQ-UHFFFAOYSA-N 0.000 claims 2
LZDZOCRKNQTXBI-UHFFFAOYSA-N 1-(2-hydroxyethyl)-4-pentylpyrrolidine-2-carboxylic acid Chemical compound CCCCCC1CC(C(O)=O)N(CCO)C1 LZDZOCRKNQTXBI-UHFFFAOYSA-N 0.000 claims 1
WGSLYMHXZQYHCE-UHFFFAOYSA-N 1-(2-hydroxyethyl)-n-[2-methyl-1-(3,4,5-trihydroxy-6-propyloxan-2-yl)propyl]-4-pentylpyrrolidine-2-carboxamide Chemical compound OCCN1CC(CCCCC)CC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(CCC)O1 WGSLYMHXZQYHCE-UHFFFAOYSA-N 0.000 claims 1
RJXIDLJYORRWLJ-UHFFFAOYSA-N 1-[2-(methylamino)-2-oxoethyl]-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-pentylpyrrolidine-2-carboxamide Chemical compound CNC(=O)CN1CC(CCCCC)CC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC)O1 RJXIDLJYORRWLJ-UHFFFAOYSA-N 0.000 claims 1
COMCSRWICCBSDR-UHFFFAOYSA-N 2-(1-amino-2-methylpropyl)-6-(2-methylsulfanylethyl)oxane-3,4,5-triol Chemical compound CSCCC1OC(C(N)C(C)C)C(O)C(O)C1O COMCSRWICCBSDR-UHFFFAOYSA-N 0.000 claims 1
HVKOAHBGTNBHRY-UHFFFAOYSA-N 2-[[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]carbamoyl]-5-(cyclopropylmethyl)azepane-1-carboxylic acid Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)Cl)NC(=O)C1N(C(O)=O)CCC(CC2CC2)CC1 HVKOAHBGTNBHRY-UHFFFAOYSA-N 0.000 claims 1
CWQJFMOBMLREAC-UHFFFAOYSA-N 4-(2,2,2-trifluoroethylsulfanyl)pyrrolidine-2-carboxylic acid Chemical compound OC(=O)C1CC(SCC(F)(F)F)CN1 CWQJFMOBMLREAC-UHFFFAOYSA-N 0.000 claims 1
CRHNWQQNNGAEER-UHFFFAOYSA-N 4-(3,3,3-trifluoropropylsulfanyl)pyrrolidine-2-carboxylic acid Chemical compound OC(=O)C1CC(SCCC(F)(F)F)CN1 CRHNWQQNNGAEER-UHFFFAOYSA-N 0.000 claims 1
KWYNZULENAEATP-UHFFFAOYSA-N 4-(3-cyanopropyl)piperidine-2-carboxylic acid Chemical compound OC(=O)C1CC(CCCC#N)CCN1 KWYNZULENAEATP-UHFFFAOYSA-N 0.000 claims 1
IPSSNWBTNLRVJF-UHFFFAOYSA-N 4-(3-cyclohexyloxypropyl)-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]piperidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)C)NC(=O)C1NCCC(CCCOC2CCCCC2)C1 IPSSNWBTNLRVJF-UHFFFAOYSA-N 0.000 claims 1
IRTDOHPCDLCCLK-UHFFFAOYSA-N 4-(3-imidazol-1-ylpropyl)piperidine-2-carboxylic acid Chemical compound C1CNC(C(=O)O)CC1CCCN1C=NC=C1 IRTDOHPCDLCCLK-UHFFFAOYSA-N 0.000 claims 1
BCLJJMPHDXTYOS-UHFFFAOYSA-N 4-(3-methylbutylsulfanyl)pyrrolidine-2-carboxylic acid Chemical compound CC(C)CCSC1CNC(C(O)=O)C1 BCLJJMPHDXTYOS-UHFFFAOYSA-N 0.000 claims 1
LYXZERIBWVQOKI-UHFFFAOYSA-N 4-(thiophen-2-ylmethylsulfanyl)pyrrolidine-2-carboxylic acid Chemical compound C1NC(C(=O)O)CC1SCC1=CC=CS1 LYXZERIBWVQOKI-UHFFFAOYSA-N 0.000 claims 1
LXPYIDVMBKEWSR-UHFFFAOYSA-N 4-[(2,4-dichlorophenyl)methylsulfanyl]pyrrolidine-2-carboxylic acid Chemical compound C1NC(C(=O)O)CC1SCC1=CC=C(Cl)C=C1Cl LXPYIDVMBKEWSR-UHFFFAOYSA-N 0.000 claims 1
YVHZPBYIMYXYOQ-UHFFFAOYSA-N 4-[(2-chlorophenyl)methylsulfanyl]-n-[2-hydroxy-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]pyrrolidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)O)NC(=O)C1NCC(SCC=2C(=CC=CC=2)Cl)C1 YVHZPBYIMYXYOQ-UHFFFAOYSA-N 0.000 claims 1
LTLKPBZNDJKLHE-UHFFFAOYSA-N 4-propylidenepiperidine-2-carboxylic acid Chemical compound CCC=C1CCNC(C(O)=O)C1 LTLKPBZNDJKLHE-UHFFFAOYSA-N 0.000 claims 1
VPYASVSTOAXXEM-UHFFFAOYSA-N N-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-3-(3-cyclobutylpropyl)azetidine-2-carboxamide 4-[3-(difluoromethylsulfanyl)propyl]piperidine-2-carboxylic acid Chemical compound FC(F)SCCCC1CC(NCC1)C(=O)O.ClC(C(C1OC(C(C(C1O)O)O)SC)NC(=O)C1NCC1CCCC1CCC1)C VPYASVSTOAXXEM-UHFFFAOYSA-N 0.000 claims 1
241000191940 Staphylococcus Species 0.000 claims 1
LIAGTEFTMYPSRZ-UHFFFAOYSA-N [4,5-dihydroxy-6-[2-methyl-1-[(4-pentylpyrrolidine-2-carbonyl)amino]propyl]-2-propyloxan-3-yl] dihydrogen phosphate Chemical compound C1C(CCCCC)CNC1C(=O)NC(C(C)C)C1C(O)C(O)C(OP(O)(O)=O)C(CCC)O1 LIAGTEFTMYPSRZ-UHFFFAOYSA-N 0.000 claims 1
JNOLRCFZNMPDIO-UHFFFAOYSA-N [4,5-dihydroxy-6-[2-methyl-1-[(4-pentylpyrrolidine-2-carbonyl)amino]propyl]-2-propyloxan-3-yl] hexadecanoate Chemical compound OC1C(O)C(OC(=O)CCCCCCCCCCCCCCC)C(CCC)OC1C(C(C)C)NC(=O)C1NCC(CCCCC)C1 JNOLRCFZNMPDIO-UHFFFAOYSA-N 0.000 claims 1
AZFCXGNLOCDOJB-UHFFFAOYSA-N [4,5-dihydroxy-6-[2-methyl-1-[(4-propylpyrrolidine-2-carbonyl)amino]propyl]-2-propyloxan-3-yl] dihydrogen phosphate Chemical compound C1C(CCC)CNC1C(=O)NC(C(C)C)C1C(O)C(O)C(OP(O)(O)=O)C(CCC)O1 AZFCXGNLOCDOJB-UHFFFAOYSA-N 0.000 claims 1
AAZJFEAFVOXPRJ-UHFFFAOYSA-N [6-[2-chloro-1-[(5-fluoro-5-propylazepane-2-carbonyl)amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] hexadecanoate Chemical compound O1C(SC)C(OC(=O)CCCCCCCCCCCCCCC)C(O)C(O)C1C(C(C)Cl)NC(=O)C1NCCC(F)(CCC)CC1 AAZJFEAFVOXPRJ-UHFFFAOYSA-N 0.000 claims 1
VZXJDJJXAKSUMN-UHFFFAOYSA-N [6-[2-chloro-1-[(5-propylazepane-2-carbonyl)amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate Chemical compound C1CC(CCC)CCNC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(OP(O)(O)=O)C(SC)O1 VZXJDJJXAKSUMN-UHFFFAOYSA-N 0.000 claims 1
244000052616 bacterial pathogen Species 0.000 claims 1
CIOSLAWOFPYTJD-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-propyl-1,2,3,6-tetrahydropyridine-2-carboxamide Chemical compound C1C(CCC)=CCNC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(O)C(SC)O1 CIOSLAWOFPYTJD-UHFFFAOYSA-N 0.000 claims 1
STVMYLXFNNOWLT-UHFFFAOYSA-N n-[2-hydroxy-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-(2,2,2-trifluoroethylsulfanyl)pyrrolidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)O)NC(=O)C1NCC(SCC(F)(F)F)C1 STVMYLXFNNOWLT-UHFFFAOYSA-N 0.000 claims 1
QISPYBSUSXGYPY-UHFFFAOYSA-N n-[2-hydroxy-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-(pyridin-2-ylmethylsulfanyl)pyrrolidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)O)NC(=O)C1NCC(SCC=2N=CC=CC=2)C1 QISPYBSUSXGYPY-UHFFFAOYSA-N 0.000 claims 1
WQWPEFCBEHKSOA-UHFFFAOYSA-N n-[2-hydroxy-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-[[4-(trifluoromethoxy)phenyl]methylsulfanyl]pyrrolidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)O)NC(=O)C1NCC(SCC=2C=CC(OC(F)(F)F)=CC=2)C1 WQWPEFCBEHKSOA-UHFFFAOYSA-N 0.000 claims 1
GCZKMIKZQQZWNE-UHFFFAOYSA-N n-[2-hydroxy-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-pyridin-4-ylsulfanylpyrrolidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)O)NC(=O)C1NCC(SC=2C=CN=CC=2)C1 GCZKMIKZQQZWNE-UHFFFAOYSA-N 0.000 claims 1
UXIKMADAIRHBGI-UHFFFAOYSA-N n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-propyl-1,2,3,6-tetrahydropyridine-2-carboxamide Chemical compound C1C(CCC)=CCNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC)O1 UXIKMADAIRHBGI-UHFFFAOYSA-N 0.000 claims 1
238000000034 method Methods 0.000 abstract description 71
230000015572 biosynthetic process Effects 0.000 abstract description 44
238000003786 synthesis reaction Methods 0.000 abstract description 43
241000894006 Bacteria Species 0.000 abstract description 9
230000000844 anti-bacterial effect Effects 0.000 abstract description 7
230000000694 effects Effects 0.000 abstract description 7
239000004599 antimicrobial Substances 0.000 abstract description 2
230000003389 potentiating effect Effects 0.000 abstract description 2
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 252
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 146
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 131
239000000047 product Substances 0.000 description 124
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 106
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 96
239000000203 mixture Substances 0.000 description 94
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 93
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 89
239000000243 solution Substances 0.000 description 88
239000011541 reaction mixture Substances 0.000 description 81
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 74
238000006243 chemical reaction Methods 0.000 description 73
229910001868 water Inorganic materials 0.000 description 70
ZMXDDKWLCZADIW-UHFFFAOYSA-N dimethylformamide Substances CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 68
235000019439 ethyl acetate Nutrition 0.000 description 63
239000000543 intermediate Substances 0.000 description 53
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 48
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 47
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 46
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 45
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 45
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 45
238000005481 NMR spectroscopy Methods 0.000 description 44
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 44
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 43
HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 42
239000012267 brine Substances 0.000 description 41
239000003153 chemical reaction reagent Substances 0.000 description 41
229920006395 saturated elastomer Polymers 0.000 description 40
239000002904 solvent Substances 0.000 description 40
125000002887 hydroxy group Chemical group [H]O* 0.000 description 39
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 36
239000007787 solid Substances 0.000 description 35
KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 32
KOFBVFFPLADGGO-DUSUDKPKSA-N (3r,4s,5r,6r)-6-[(1r,2r)-1-amino-2-hydroxypropyl]oxane-2,3,4,5-tetrol Chemical compound C[C@@H](O)[C@@H](N)[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O KOFBVFFPLADGGO-DUSUDKPKSA-N 0.000 description 29
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 29
239000004480 active ingredient Substances 0.000 description 28
239000003960 organic solvent Substances 0.000 description 28
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 26
WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 25
229910052943 magnesium sulfate Inorganic materials 0.000 description 24
235000019341 magnesium sulphate Nutrition 0.000 description 24
238000003756 stirring Methods 0.000 description 24
238000007792 addition Methods 0.000 description 23
239000012043 crude product Substances 0.000 description 23
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 23
OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 22
239000002585 base Substances 0.000 description 22
239000010410 layer Substances 0.000 description 22
239000011734 sodium Substances 0.000 description 22
RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 21
238000009472 formulation Methods 0.000 description 21
235000017557 sodium bicarbonate Nutrition 0.000 description 21
229910000030 sodium bicarbonate Inorganic materials 0.000 description 21
229940093499 ethyl acetate Drugs 0.000 description 20
239000012044 organic layer Substances 0.000 description 20
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 19
HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 19
239000003921 oil Substances 0.000 description 19
235000019198 oils Nutrition 0.000 description 19
238000000746 purification Methods 0.000 description 19
239000000741 silica gel Substances 0.000 description 19
229910002027 silica gel Inorganic materials 0.000 description 19
238000004587 chromatography analysis Methods 0.000 description 18
239000003480 eluent Substances 0.000 description 18
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 18
229920005989 resin Polymers 0.000 description 18
239000011347 resin Substances 0.000 description 18
101150041968 CDC13 gene Proteins 0.000 description 17
125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 17
QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 16
WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 16
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 16
PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 16
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 15
239000003242 anti bacterial agent Substances 0.000 description 15
235000015165 citric acid Nutrition 0.000 description 15
201000010099 disease Diseases 0.000 description 15
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
239000000706 filtrate Substances 0.000 description 15
239000004615 ingredient Substances 0.000 description 15
239000000463 material Substances 0.000 description 15
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 14
238000005859 coupling reaction Methods 0.000 description 14
229910052938 sodium sulfate Inorganic materials 0.000 description 14
235000011152 sodium sulphate Nutrition 0.000 description 14
238000005406 washing Methods 0.000 description 14
SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 12
XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 12
CSJLBAMHHLJAAS-UHFFFAOYSA-N diethylaminosulfur trifluoride Chemical compound CCN(CC)S(F)(F)F CSJLBAMHHLJAAS-UHFFFAOYSA-N 0.000 description 12
150000007530 organic bases Chemical class 0.000 description 12
125000006239 protecting group Chemical group 0.000 description 12
238000004809 thin layer chromatography Methods 0.000 description 12
RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 12
LVZWSLJZHVFIQJ-UHFFFAOYSA-N Cyclopropane Chemical compound C1CC1 LVZWSLJZHVFIQJ-UHFFFAOYSA-N 0.000 description 11
JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 11
125000004432 carbon atom Chemical group C* 0.000 description 11
230000008878 coupling Effects 0.000 description 11
238000010168 coupling process Methods 0.000 description 11
238000003818 flash chromatography Methods 0.000 description 11
239000000546 pharmaceutical excipient Substances 0.000 description 11
235000020357 syrup Nutrition 0.000 description 11
239000006188 syrup Substances 0.000 description 11
229920002472 Starch Polymers 0.000 description 10
239000003495 polar organic solvent Substances 0.000 description 10
BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 10
235000019698 starch Nutrition 0.000 description 10
239000000725 suspension Substances 0.000 description 10
239000003826 tablet Substances 0.000 description 10
239000007832 Na2SO4 Substances 0.000 description 9
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 9
NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 9
229940024606 amino acid Drugs 0.000 description 9
235000001014 amino acid Nutrition 0.000 description 9
239000012230 colorless oil Substances 0.000 description 9
150000003951 lactams Chemical class 0.000 description 9
YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 9
235000013930 proline Nutrition 0.000 description 9
230000009467 reduction Effects 0.000 description 9
238000010898 silica gel chromatography Methods 0.000 description 9
239000008107 starch Substances 0.000 description 9
239000000126 substance Substances 0.000 description 9
WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 8
125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 8
DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 8
238000005804 alkylation reaction Methods 0.000 description 8
229910052799 carbon Inorganic materials 0.000 description 8
238000004128 high performance liquid chromatography Methods 0.000 description 8
235000019359 magnesium stearate Nutrition 0.000 description 8
CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 8
239000002245 particle Substances 0.000 description 8
239000000843 powder Substances 0.000 description 8
229960002429 proline Drugs 0.000 description 8
239000000377 silicon dioxide Substances 0.000 description 8
208000024891 symptom Diseases 0.000 description 8
JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 8
QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 8
241000192125 Firmicutes Species 0.000 description 7
XLYOFNOQVPJJNP-ZSJDYOACSA-N Heavy water Chemical compound [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 7
239000003795 chemical substances by application Substances 0.000 description 7
239000002552 dosage form Substances 0.000 description 7
229940079593 drug Drugs 0.000 description 7
239000011521 glass Substances 0.000 description 7
150000004702 methyl esters Chemical class 0.000 description 7
SIOXPEMLGUPBBT-UHFFFAOYSA-N picolinic acid Chemical class OC(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-N 0.000 description 7
238000002360 preparation method Methods 0.000 description 7
150000003222 pyridines Chemical class 0.000 description 7
125000000719 pyrrolidinyl group Chemical group 0.000 description 7
230000002829 reductive effect Effects 0.000 description 7
PJUPKRYGDFTMTM-UHFFFAOYSA-N 1-hydroxybenzotriazole;hydrate Chemical compound O.C1=CC=C2N(O)N=NC2=C1 PJUPKRYGDFTMTM-UHFFFAOYSA-N 0.000 description 6
BKOOMYPCSUNDGP-UHFFFAOYSA-N 2-methylbut-2-ene Chemical group CC=C(C)C BKOOMYPCSUNDGP-UHFFFAOYSA-N 0.000 description 6
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
239000004215 Carbon black (E152) Substances 0.000 description 6
239000007821 HATU Substances 0.000 description 6
SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 6
OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 6
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
150000007513 acids Chemical class 0.000 description 6
150000001299 aldehydes Chemical class 0.000 description 6
150000001336 alkenes Chemical class 0.000 description 6
239000007864 aqueous solution Substances 0.000 description 6
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 6
238000001704 evaporation Methods 0.000 description 6
150000002374 hemiaminals Chemical class 0.000 description 6
229930195733 hydrocarbon Natural products 0.000 description 6
238000005984 hydrogenation reaction Methods 0.000 description 6
NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 6
RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
229920001467 poly(styrenesulfonates) Polymers 0.000 description 6
229960003908 pseudoephedrine Drugs 0.000 description 6
125000006413 ring segment Chemical group 0.000 description 6
230000001225 therapeutic effect Effects 0.000 description 6
RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 6
DNUTZBZXLPWRJG-UHFFFAOYSA-N 1-Piperidine carboxylic acid Chemical compound OC(=O)N1CCCCC1 DNUTZBZXLPWRJG-UHFFFAOYSA-N 0.000 description 5
KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 5
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 5
FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 5
229910019142 PO4 Inorganic materials 0.000 description 5
239000002168 alkylating agent Substances 0.000 description 5
229940100198 alkylating agent Drugs 0.000 description 5
230000029936 alkylation Effects 0.000 description 5
239000002775 capsule Substances 0.000 description 5
150000001732 carboxylic acid derivatives Chemical class 0.000 description 5
238000007796 conventional method Methods 0.000 description 5
238000002425 crystallisation Methods 0.000 description 5
230000008025 crystallization Effects 0.000 description 5
125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 5
KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 5
238000010511 deprotection reaction Methods 0.000 description 5
229940113088 dimethylacetamide Drugs 0.000 description 5
JZXVIASGAMNRDD-UHFFFAOYSA-N ethyl 2-(prop-2-enylamino)acetate Chemical compound CCOC(=O)CNCC=C JZXVIASGAMNRDD-UHFFFAOYSA-N 0.000 description 5
230000008020 evaporation Effects 0.000 description 5
239000000284 extract Substances 0.000 description 5
238000001914 filtration Methods 0.000 description 5
239000007903 gelatin capsule Substances 0.000 description 5
IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 5
239000012299 nitrogen atmosphere Substances 0.000 description 5
QMMOXUPEWRXHJS-UHFFFAOYSA-N pentene-2 Natural products CCC=CC QMMOXUPEWRXHJS-UHFFFAOYSA-N 0.000 description 5
239000010452 phosphate Substances 0.000 description 5
125000005936 piperidyl group Chemical group 0.000 description 5
239000011148 porous material Substances 0.000 description 5
229910000027 potassium carbonate Inorganic materials 0.000 description 5
KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Substances [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 5
150000003148 prolines Chemical class 0.000 description 5
KWGRBVOPPLSCSI-WCBMZHEXSA-N pseudoephedrine Chemical compound CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WCBMZHEXSA-N 0.000 description 5
238000010992 reflux Methods 0.000 description 5
238000001228 spectrum Methods 0.000 description 5
239000007858 starting material Substances 0.000 description 5
FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 5
UWYZHKAOTLEWKK-UHFFFAOYSA-N 1,2,3,4-tetrahydroisoquinoline Chemical compound C1=CC=C2CNCCC2=C1 UWYZHKAOTLEWKK-UHFFFAOYSA-N 0.000 description 4
BWZVCCNYKMEVEX-UHFFFAOYSA-N 2,4,6-Trimethylpyridine Chemical compound CC1=CC(C)=NC(C)=C1 BWZVCCNYKMEVEX-UHFFFAOYSA-N 0.000 description 4
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
229910015900 BF3 Inorganic materials 0.000 description 4
CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 4
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 4
241000233866 Fungi Species 0.000 description 4
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 4
241001465754 Metazoa Species 0.000 description 4
229920000168 Microcrystalline cellulose Polymers 0.000 description 4
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 4
125000002947 alkylene group Chemical group 0.000 description 4
229910000147 aluminium phosphate Inorganic materials 0.000 description 4
WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 4
FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 4
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 4
238000004113 cell culture Methods 0.000 description 4
125000001309 chloro group Chemical group Cl* 0.000 description 4
238000004440 column chromatography Methods 0.000 description 4
239000013078 crystal Substances 0.000 description 4
125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 4
238000006073 displacement reaction Methods 0.000 description 4
PQVSTLUFSYVLTO-UHFFFAOYSA-N ethyl n-ethoxycarbonylcarbamate Chemical compound CCOC(=O)NC(=O)OCC PQVSTLUFSYVLTO-UHFFFAOYSA-N 0.000 description 4
125000000524 functional group Chemical group 0.000 description 4
125000005842 heteroatom Chemical group 0.000 description 4
238000001727 in vivo Methods 0.000 description 4
KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 4
229940040692 lithium hydroxide monohydrate Drugs 0.000 description 4
GLXDVVHUTZTUQK-UHFFFAOYSA-M lithium hydroxide monohydrate Substances [Li+].O.[OH-] GLXDVVHUTZTUQK-UHFFFAOYSA-M 0.000 description 4
VTENWIPSWAMPKI-UHFFFAOYSA-N methyl 4-chloropyridine-2-carboxylate Chemical compound COC(=O)C1=CC(Cl)=CC=N1 VTENWIPSWAMPKI-UHFFFAOYSA-N 0.000 description 4
235000019813 microcrystalline cellulose Nutrition 0.000 description 4
239000008108 microcrystalline cellulose Substances 0.000 description 4
229940016286 microcrystalline cellulose Drugs 0.000 description 4
125000002950 monocyclic group Chemical group 0.000 description 4
239000012038 nucleophile Substances 0.000 description 4
239000012074 organic phase Substances 0.000 description 4
244000045947 parasite Species 0.000 description 4
244000052769 pathogen Species 0.000 description 4
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 4
150000004714 phosphonium salts Chemical class 0.000 description 4
239000006187 pill Substances 0.000 description 4
CHKVPAROMQMJNQ-UHFFFAOYSA-M potassium bisulfate Chemical compound [K+].OS([O-])(=O)=O CHKVPAROMQMJNQ-UHFFFAOYSA-M 0.000 description 4
229910000343 potassium bisulfate Inorganic materials 0.000 description 4
235000011181 potassium carbonates Nutrition 0.000 description 4
239000002244 precipitate Substances 0.000 description 4
229910000104 sodium hydride Inorganic materials 0.000 description 4
DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 4
238000012360 testing method Methods 0.000 description 4
230000009466 transformation Effects 0.000 description 4
MZMNEDXVUJLQAF-SFYZADRCSA-N 1-o-tert-butyl 2-o-methyl (2s,4r)-4-hydroxypyrrolidine-1,2-dicarboxylate Chemical compound COC(=O)[C@@H]1C[C@@H](O)CN1C(=O)OC(C)(C)C MZMNEDXVUJLQAF-SFYZADRCSA-N 0.000 description 3
NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 3
RYJUXWGBKKKTMC-UHFFFAOYSA-N 5-propylazepane-2-carboxylic acid Chemical compound CCCC1CCNC(C(O)=O)CC1 RYJUXWGBKKKTMC-UHFFFAOYSA-N 0.000 description 3
VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical compound NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 description 3
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 3
208000035143 Bacterial infection Diseases 0.000 description 3
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
DCERHCFNWRGHLK-UHFFFAOYSA-N C[Si](C)C Chemical compound C[Si](C)C DCERHCFNWRGHLK-UHFFFAOYSA-N 0.000 description 3
KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 3
208000007190 Chlamydia Infections Diseases 0.000 description 3
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 3
241000282412 Homo Species 0.000 description 3
SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 3
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
OJMMVQQUTAEWLP-UHFFFAOYSA-N Lincomycin Natural products CN1CC(CCC)CC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 OJMMVQQUTAEWLP-UHFFFAOYSA-N 0.000 description 3
OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
206010028470 Mycoplasma infections Diseases 0.000 description 3
XCOBLONWWXQEBS-KPKJPENVSA-N N,O-bis(trimethylsilyl)trifluoroacetamide Chemical compound C[Si](C)(C)O\C(C(F)(F)F)=N\[Si](C)(C)C XCOBLONWWXQEBS-KPKJPENVSA-N 0.000 description 3
PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 3
101100272976 Panax ginseng CYP716A53v2 gene Proteins 0.000 description 3
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 3
KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
229930006000 Sucrose Natural products 0.000 description 3
125000002252 acyl group Chemical group 0.000 description 3
125000004442 acylamino group Chemical group 0.000 description 3
YKIOKAURTKXMSB-UHFFFAOYSA-N adams's catalyst Chemical compound O=[Pt]=O YKIOKAURTKXMSB-UHFFFAOYSA-N 0.000 description 3
125000000746 allylic group Chemical group 0.000 description 3
150000001413 amino acids Chemical class 0.000 description 3
238000010171 animal model Methods 0.000 description 3
238000003556 assay Methods 0.000 description 3
208000022362 bacterial infectious disease Diseases 0.000 description 3
WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
XSCHRSMBECNVNS-UHFFFAOYSA-N benzopyrazine Natural products N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 description 3
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 3
125000000649 benzylidene group Chemical group [H]C(=[*])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 3
230000008499 blood brain barrier function Effects 0.000 description 3
210000001218 blood-brain barrier Anatomy 0.000 description 3
229910052794 bromium Inorganic materials 0.000 description 3
125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
150000001721 carbon Chemical group 0.000 description 3
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 3
239000000969 carrier Substances 0.000 description 3
239000003638 chemical reducing agent Substances 0.000 description 3
229910052801 chlorine Inorganic materials 0.000 description 3
229960002227 clindamycin Drugs 0.000 description 3
KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 3
238000010549 co-Evaporation Methods 0.000 description 3
238000001816 cooling Methods 0.000 description 3
150000001993 dienes Chemical class 0.000 description 3
GRRSDGHTSMJICM-UHFFFAOYSA-N diethyl 2-propylpropanedioate Chemical compound CCOC(=O)C(CCC)C(=O)OCC GRRSDGHTSMJICM-UHFFFAOYSA-N 0.000 description 3
PQJJJMRNHATNKG-UHFFFAOYSA-N ethyl bromoacetate Chemical compound CCOC(=O)CBr PQJJJMRNHATNKG-UHFFFAOYSA-N 0.000 description 3
239000000796 flavoring agent Substances 0.000 description 3
229910052731 fluorine Inorganic materials 0.000 description 3
238000007429 general method Methods 0.000 description 3
150000002430 hydrocarbons Chemical group 0.000 description 3
230000007062 hydrolysis Effects 0.000 description 3
238000006460 hydrolysis reaction Methods 0.000 description 3
125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 3
239000005457 ice water Substances 0.000 description 3
230000002401 inhibitory effect Effects 0.000 description 3
238000001990 intravenous administration Methods 0.000 description 3
239000008101 lactose Substances 0.000 description 3
229960005287 lincomycin Drugs 0.000 description 3
239000007788 liquid Substances 0.000 description 3
239000002609 medium Substances 0.000 description 3
VMVNZNXAVJHNDJ-UHFFFAOYSA-N methyl 2,2,2-trifluoroacetate Chemical compound COC(=O)C(F)(F)F VMVNZNXAVJHNDJ-UHFFFAOYSA-N 0.000 description 3
230000004048 modification Effects 0.000 description 3
238000012986 modification Methods 0.000 description 3
238000005949 ozonolysis reaction Methods 0.000 description 3
125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 3
229910052698 phosphorus Inorganic materials 0.000 description 3
239000011574 phosphorus Substances 0.000 description 3
239000001267 polyvinylpyrrolidone Substances 0.000 description 3
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
235000015497 potassium bicarbonate Nutrition 0.000 description 3
229910000028 potassium bicarbonate Inorganic materials 0.000 description 3
239000011736 potassium bicarbonate Substances 0.000 description 3
TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 3
LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 3
230000008569 process Effects 0.000 description 3
ZDYVRSLAEXCVBX-UHFFFAOYSA-N pyridinium p-toluenesulfonate Chemical compound C1=CC=[NH+]C=C1.CC1=CC=C(S([O-])(=O)=O)C=C1 ZDYVRSLAEXCVBX-UHFFFAOYSA-N 0.000 description 3
238000010791 quenching Methods 0.000 description 3
229910052707 ruthenium Inorganic materials 0.000 description 3
239000012312 sodium hydride Substances 0.000 description 3
239000005720 sucrose Substances 0.000 description 3
239000000829 suppository Substances 0.000 description 3
238000010189 synthetic method Methods 0.000 description 3
239000000454 talc Substances 0.000 description 3
229910052623 talc Inorganic materials 0.000 description 3
235000012222 talc Nutrition 0.000 description 3
125000003396 thiol group Chemical group [H]S* 0.000 description 3
LEIMLDGFXIOXMT-UHFFFAOYSA-N trimethylsilyl cyanide Chemical compound C[Si](C)(C)C#N LEIMLDGFXIOXMT-UHFFFAOYSA-N 0.000 description 3
VUDZSIYXZUYWSC-DBRKOABJSA-N (4r)-1-[(2r,4r,5r)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1,3-diazinan-2-one Chemical compound FC1(F)[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)N[C@H](O)CC1 VUDZSIYXZUYWSC-DBRKOABJSA-N 0.000 description 2
LBUJPTNKIBCYBY-UHFFFAOYSA-N 1,2,3,4-tetrahydroquinoline Chemical compound C1=CC=C2CCCNC2=C1 LBUJPTNKIBCYBY-UHFFFAOYSA-N 0.000 description 2
AUHZEENZYGFFBQ-UHFFFAOYSA-N 1,3,5-Me3C6H3 Natural products CC1=CC(C)=CC(C)=C1 AUHZEENZYGFFBQ-UHFFFAOYSA-N 0.000 description 2
YKNDCTKMKVIEFP-UHFFFAOYSA-N 1-(chloromethylidene)piperidin-1-ium Chemical compound ClC=[N+]1CCCCC1 YKNDCTKMKVIEFP-UHFFFAOYSA-N 0.000 description 2
NNHYAHOTXLASEA-UHFFFAOYSA-N 1-(dimethoxymethyl)-4-methoxybenzene Chemical compound COC(OC)C1=CC=C(OC)C=C1 NNHYAHOTXLASEA-UHFFFAOYSA-N 0.000 description 2
FEWLNYSYJNLUOO-UHFFFAOYSA-N 1-Piperidinecarboxaldehyde Chemical compound O=CN1CCCCC1 FEWLNYSYJNLUOO-UHFFFAOYSA-N 0.000 description 2
FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical compound C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 description 2
LOYZVRIHVZEDMW-UHFFFAOYSA-N 1-bromo-3-methylbut-2-ene Chemical compound CC(C)=CCBr LOYZVRIHVZEDMW-UHFFFAOYSA-N 0.000 description 2
HNEGJTWNOOWEMH-UHFFFAOYSA-N 1-fluoropropane Chemical group [CH2]CCF HNEGJTWNOOWEMH-UHFFFAOYSA-N 0.000 description 2
238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 2
238000005160 1H NMR spectroscopy Methods 0.000 description 2
NRKYWOKHZRQRJR-UHFFFAOYSA-N 2,2,2-trifluoroacetamide Chemical compound NC(=O)C(F)(F)F NRKYWOKHZRQRJR-UHFFFAOYSA-N 0.000 description 2
HBEDSQVIWPRPAY-UHFFFAOYSA-N 2,3-dihydrobenzofuran Chemical compound C1=CC=C2OCCC2=C1 HBEDSQVIWPRPAY-UHFFFAOYSA-N 0.000 description 2
125000000134 2-(methylsulfanyl)ethyl group Chemical group [H]C([H])([H])SC([H])([H])C([H])([H])[*] 0.000 description 2
YSULOORXQBDPCU-UHFFFAOYSA-N 2-(trimethylazaniumyl)ethanehydrazonate;hydrochloride Chemical compound [Cl-].C[N+](C)(C)CC(=O)NN YSULOORXQBDPCU-UHFFFAOYSA-N 0.000 description 2
HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 2
KWMBADTWRIGGGG-UHFFFAOYSA-N 2-diethoxyphosphorylacetonitrile Chemical compound CCOP(=O)(CC#N)OCC KWMBADTWRIGGGG-UHFFFAOYSA-N 0.000 description 2
ZYXZSRASZWYYFY-UHFFFAOYSA-N 2-ethoxycarbonylpentanoic acid Chemical compound CCCC(C(O)=O)C(=O)OCC ZYXZSRASZWYYFY-UHFFFAOYSA-N 0.000 description 2
YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 2
WPHUUIODWRNJLO-UHFFFAOYSA-N 2-nitrobenzenesulfonyl chloride Chemical compound [O-][N+](=O)C1=CC=CC=C1S(Cl)(=O)=O WPHUUIODWRNJLO-UHFFFAOYSA-N 0.000 description 2
QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 2
MLSLWQHJKLGJOT-UHFFFAOYSA-N 4-(3-ethylsulfanylpropyl)piperidine-2-carboxylic acid Chemical compound CCSCCCC1CCNC(C(O)=O)C1 MLSLWQHJKLGJOT-UHFFFAOYSA-N 0.000 description 2
CEYJTEYGGAWURJ-UHFFFAOYSA-N 4-iodopyridine-2-carboxylic acid Chemical compound OC(=O)C1=CC(I)=CC=N1 CEYJTEYGGAWURJ-UHFFFAOYSA-N 0.000 description 2
SWBGPJIGJIFMFZ-UHFFFAOYSA-N 4-pentylpyrrolidine-2-carboxylic acid Chemical compound CCCCCC1CNC(C(O)=O)C1 SWBGPJIGJIFMFZ-UHFFFAOYSA-N 0.000 description 2
JAWZAONCXMJLFT-UHFFFAOYSA-N 4-propylpyridine Chemical compound CCCC1=CC=NC=C1 JAWZAONCXMJLFT-UHFFFAOYSA-N 0.000 description 2
MKYMNDRGKIIVIE-UHFFFAOYSA-N 4-propylpyridine-2-carboxylic acid Chemical compound CCCC1=CC=NC(C(O)=O)=C1 MKYMNDRGKIIVIE-UHFFFAOYSA-N 0.000 description 2
KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 2
XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 2
RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical group OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
YIIMEMSDCNDGTB-UHFFFAOYSA-N Dimethylcarbamoyl chloride Chemical compound CN(C)C(Cl)=O YIIMEMSDCNDGTB-UHFFFAOYSA-N 0.000 description 2
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
XOGTZOOQQBDUSI-UHFFFAOYSA-M Mesna Chemical compound [Na+].[O-]S(=O)(=O)CCS XOGTZOOQQBDUSI-UHFFFAOYSA-M 0.000 description 2
IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
101100030361 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pph-3 gene Proteins 0.000 description 2
229910020667 PBr3 Inorganic materials 0.000 description 2
PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 2
GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
229910019020 PtO2 Inorganic materials 0.000 description 2
KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 2
KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
241000191963 Staphylococcus epidermidis Species 0.000 description 2
235000021355 Stearic acid Nutrition 0.000 description 2
STSCVKRWJPWALQ-UHFFFAOYSA-N TRIFLUOROACETIC ACID ETHYL ESTER Chemical compound CCOC(=O)C(F)(F)F STSCVKRWJPWALQ-UHFFFAOYSA-N 0.000 description 2
239000004809 Teflon Substances 0.000 description 2
229920006362 Teflon® Polymers 0.000 description 2
YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
230000003213 activating effect Effects 0.000 description 2
238000005865 alkene metathesis reaction Methods 0.000 description 2
150000001350 alkyl halides Chemical class 0.000 description 2
150000001408 amides Chemical class 0.000 description 2
125000003277 amino group Chemical group 0.000 description 2
125000005097 aminocarbonylalkyl group Chemical group 0.000 description 2
229910021529 ammonia Inorganic materials 0.000 description 2
239000008365 aqueous carrier Substances 0.000 description 2
239000008346 aqueous phase Substances 0.000 description 2
239000012298 atmosphere Substances 0.000 description 2
MEOZFUYXLCDYGA-UHFFFAOYSA-N azepane-1-carboxylic acid Chemical compound OC(=O)N1CCCCCC1 MEOZFUYXLCDYGA-UHFFFAOYSA-N 0.000 description 2
230000008901 benefit Effects 0.000 description 2
239000012455 biphasic mixture Substances 0.000 description 2
229910000024 caesium carbonate Inorganic materials 0.000 description 2
150000001718 carbodiimides Chemical class 0.000 description 2
239000001768 carboxy methyl cellulose Substances 0.000 description 2
150000001735 carboxylic acids Chemical class 0.000 description 2
239000003054 catalyst Substances 0.000 description 2
235000010980 cellulose Nutrition 0.000 description 2
229920002678 cellulose Polymers 0.000 description 2
239000001913 cellulose Substances 0.000 description 2
229920001429 chelating resin Polymers 0.000 description 2
238000003776 cleavage reaction Methods 0.000 description 2
125000004122 cyclic group Chemical group 0.000 description 2
125000004850 cyclobutylmethyl group Chemical group C1(CCC1)C* 0.000 description 2
125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
UURSXESKOOOTOV-UHFFFAOYSA-N dec-5-ene Chemical compound CCCCC=CCCCC UURSXESKOOOTOV-UHFFFAOYSA-N 0.000 description 2
230000003111 delayed effect Effects 0.000 description 2
YNLAOSYQHBDIKW-UHFFFAOYSA-M diethylaluminium chloride Chemical compound CC[Al](Cl)CC YNLAOSYQHBDIKW-UHFFFAOYSA-M 0.000 description 2
XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
238000012377 drug delivery Methods 0.000 description 2
238000000132 electrospray ionisation Methods 0.000 description 2
238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 2
239000008387 emulsifying waxe Substances 0.000 description 2
239000000839 emulsion Substances 0.000 description 2
239000012055 enteric layer Substances 0.000 description 2
239000012259 ether extract Substances 0.000 description 2
125000004705 ethylthio group Chemical group C(C)S* 0.000 description 2
235000019634 flavors Nutrition 0.000 description 2
239000011737 fluorine Substances 0.000 description 2
235000019256 formaldehyde Nutrition 0.000 description 2
229930182830 galactose Natural products 0.000 description 2
244000000058 gram-negative pathogen Species 0.000 description 2
239000008187 granular material Substances 0.000 description 2
230000002140 halogenating effect Effects 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 2
229960002163 hydrogen peroxide Drugs 0.000 description 2
238000007327 hydrogenolysis reaction Methods 0.000 description 2
150000002466 imines Chemical class 0.000 description 2
238000001802 infusion Methods 0.000 description 2
229910052740 iodine Inorganic materials 0.000 description 2
SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 2
AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
231100000518 lethal Toxicity 0.000 description 2
230000001665 lethal effect Effects 0.000 description 2
239000002502 liposome Substances 0.000 description 2
229940057995 liquid paraffin Drugs 0.000 description 2
238000004949 mass spectrometry Methods 0.000 description 2
229960004635 mesna Drugs 0.000 description 2
QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 2
HSNLSLNACLYWKJ-UHFFFAOYSA-N methyl 4-iodopyridine-2-carboxylate Chemical compound COC(=O)C1=CC(I)=CC=N1 HSNLSLNACLYWKJ-UHFFFAOYSA-N 0.000 description 2
LSEFCHWGJNHZNT-UHFFFAOYSA-M methyl(triphenyl)phosphanium;bromide Chemical compound [Br-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(C)C1=CC=CC=C1 LSEFCHWGJNHZNT-UHFFFAOYSA-M 0.000 description 2
239000002480 mineral oil Substances 0.000 description 2
235000010446 mineral oil Nutrition 0.000 description 2
TXXHDPDFNKHHGW-UHFFFAOYSA-N muconic acid Chemical group OC(=O)C=CC=CC(O)=O TXXHDPDFNKHHGW-UHFFFAOYSA-N 0.000 description 2
FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
SAVQQRYWWAGSQW-UHFFFAOYSA-N n-methyl-n-(trifluoro-$l^{4}-sulfanyl)methanamine Chemical compound CN(C)S(F)(F)F SAVQQRYWWAGSQW-UHFFFAOYSA-N 0.000 description 2
125000006574 non-aromatic ring group Chemical group 0.000 description 2
230000000269 nucleophilic effect Effects 0.000 description 2
AEKHNNJSMVVESS-UHFFFAOYSA-N o-trimethylsilylhydroxylamine Chemical compound C[Si](C)(C)ON AEKHNNJSMVVESS-UHFFFAOYSA-N 0.000 description 2
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical group CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Chemical group CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
125000001979 organolithium group Chemical group 0.000 description 2
239000007800 oxidant agent Substances 0.000 description 2
150000002923 oximes Chemical group 0.000 description 2
MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 2
YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 2
239000012188 paraffin wax Substances 0.000 description 2
239000008177 pharmaceutical agent Substances 0.000 description 2
229940124531 pharmaceutical excipient Drugs 0.000 description 2
RDOWQLZANAYVLL-UHFFFAOYSA-N phenanthridine Chemical compound C1=CC=C2C3=CC=CC=C3C=NC2=C1 RDOWQLZANAYVLL-UHFFFAOYSA-N 0.000 description 2
IPNPIHIZVLFAFP-UHFFFAOYSA-N phosphorus tribromide Chemical compound BrP(Br)Br IPNPIHIZVLFAFP-UHFFFAOYSA-N 0.000 description 2
229910003446 platinum oxide Inorganic materials 0.000 description 2
NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 2
150000003138 primary alcohols Chemical class 0.000 description 2
YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical group OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
230000007017 scission Effects 0.000 description 2
210000002966 serum Anatomy 0.000 description 2
239000002002 slurry Substances 0.000 description 2
229910052708 sodium Inorganic materials 0.000 description 2
WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
239000004299 sodium benzoate Substances 0.000 description 2
235000010234 sodium benzoate Nutrition 0.000 description 2
239000012279 sodium borohydride Substances 0.000 description 2
229910000033 sodium borohydride Inorganic materials 0.000 description 2
JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 2
235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
239000008247 solid mixture Substances 0.000 description 2
241000894007 species Species 0.000 description 2
239000003381 stabilizer Substances 0.000 description 2
239000008117 stearic acid Chemical group 0.000 description 2
230000000707 stereoselective effect Effects 0.000 description 2
239000008223 sterile water Substances 0.000 description 2
230000001954 sterilising effect Effects 0.000 description 2
238000004659 sterilization and disinfection Methods 0.000 description 2
239000012258 stirred mixture Substances 0.000 description 2
KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 2
GFYHSKONPJXCDE-UHFFFAOYSA-N sym-collidine Natural products CC1=CN=C(C)C(C)=C1 GFYHSKONPJXCDE-UHFFFAOYSA-N 0.000 description 2
125000004213 tert-butoxy group Chemical group [H]C([H])([H])C(O*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
XJPKDRJZNZMJQM-UHFFFAOYSA-N tetrakis(prop-2-enyl)stannane Chemical compound C=CC[Sn](CC=C)(CC=C)CC=C XJPKDRJZNZMJQM-UHFFFAOYSA-N 0.000 description 2
125000004568 thiomorpholinyl group Chemical group 0.000 description 2
FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
ONDSBJMLAHVLMI-UHFFFAOYSA-N trimethylsilyldiazomethane Chemical compound C[Si](C)(C)[CH-][N+]#N ONDSBJMLAHVLMI-UHFFFAOYSA-N 0.000 description 2
UCPYLLCMEDAXFR-UHFFFAOYSA-N triphosgene Chemical compound ClC(Cl)(Cl)OC(=O)OC(Cl)(Cl)Cl UCPYLLCMEDAXFR-UHFFFAOYSA-N 0.000 description 2
125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
239000003039 volatile agent Substances 0.000 description 2
238000005303 weighing Methods 0.000 description 2
229910009112 xH2O Inorganic materials 0.000 description 2
239000000230 xanthan gum Substances 0.000 description 2
235000010493 xanthan gum Nutrition 0.000 description 2
229920001285 xanthan gum Polymers 0.000 description 2
229940082509 xanthan gum Drugs 0.000 description 2
150000003751 zinc Chemical class 0.000 description 2
VPAHTUQECJIGCK-UHFFFAOYSA-N (2-methylphenyl)sulfonyl 2-methylbenzenesulfonate Chemical compound CC1=CC=CC=C1S(=O)(=O)OS(=O)(=O)C1=CC=CC=C1C VPAHTUQECJIGCK-UHFFFAOYSA-N 0.000 description 1
QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
CAODDCZFBZNYSO-BYPYZUCNSA-N (2s)-3-oxopyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@H]1NCCC1=O CAODDCZFBZNYSO-BYPYZUCNSA-N 0.000 description 1
XTQZONYRNXFGCY-MLWJPKLSSA-N (2s)-4-[(2-methylpropan-2-yl)oxy]pyrrolidine-2-carboxylic acid Chemical compound CC(C)(C)OC1CN[C@H](C(O)=O)C1 XTQZONYRNXFGCY-MLWJPKLSSA-N 0.000 description 1
WVTLNQDWHKEMBI-LLTODGECSA-N (2s)-4-fluoro-1-[(2-methylpropan-2-yl)oxycarbonyl]-4-propylpyrrolidine-2-carboxylic acid Chemical compound CCCC1(F)C[C@@H](C(O)=O)N(C(=O)OC(C)(C)C)C1 WVTLNQDWHKEMBI-LLTODGECSA-N 0.000 description 1
BENKAPCDIOILGV-RQJHMYQMSA-N (2s,4r)-4-hydroxy-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid Chemical compound CC(C)(C)OC(=O)N1C[C@H](O)C[C@H]1C(O)=O BENKAPCDIOILGV-RQJHMYQMSA-N 0.000 description 1
TWYYFYNJOJGNFP-CUXYNZQBSA-N (2s,4r,5s,6s)-2-[(4s,5r)-4-acetyloxy-5-methyl-3-methylidene-6-phenylhexyl]-2-carbamoyl-4-[[(e,4s,6s)-4,6-dimethyloct-2-enoyl]oxymethyl]-5-hydroxy-1,3-dioxane-4,5,6-tricarboxylic acid Chemical compound O1[C@H](C(O)=O)[C@](C(O)=O)(O)[C@](COC(=O)/C=C/[C@@H](C)C[C@@H](C)CC)(C(O)=O)O[C@]1(C(N)=O)CCC(=C)[C@@H](OC(C)=O)[C@H](C)CC1=CC=CC=C1 TWYYFYNJOJGNFP-CUXYNZQBSA-N 0.000 description 1
JPYHXSWNADKGBI-SVZMEOIVSA-N (3r,4s,5r,6r)-2-chloro-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound OC[C@H]1OC(Cl)[C@H](O)[C@@H](O)[C@H]1O JPYHXSWNADKGBI-SVZMEOIVSA-N 0.000 description 1
BIKDOQRECXQNQR-UHFFFAOYSA-N (4-chlorophenyl)methylphosphanium;chloride Chemical compound [Cl-].[PH3+]CC1=CC=C(Cl)C=C1 BIKDOQRECXQNQR-UHFFFAOYSA-N 0.000 description 1
PDVFSPNIEOYOQL-UHFFFAOYSA-N (4-methylphenyl)sulfonyl 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)OS(=O)(=O)C1=CC=C(C)C=C1 PDVFSPNIEOYOQL-UHFFFAOYSA-N 0.000 description 1
MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 1
BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
AVMHMVJVHYGDOO-NSCUHMNNSA-N (e)-1-bromobut-2-ene Chemical compound C\C=C\CBr AVMHMVJVHYGDOO-NSCUHMNNSA-N 0.000 description 1
IGVKWAAPMVVTFX-BUHFOSPRSA-N (e)-octadec-5-en-7,9-diynoic acid Chemical compound CCCCCCCCC#CC#C\C=C\CCCC(O)=O IGVKWAAPMVVTFX-BUHFOSPRSA-N 0.000 description 1
YHLIEGBCOUQKHU-UHFFFAOYSA-N 1,1-difluoroprop-1-ene Chemical group CC=C(F)F YHLIEGBCOUQKHU-UHFFFAOYSA-N 0.000 description 1
CTJAKAQLCQKBTC-UHFFFAOYSA-N 1,1-difluoropropane Chemical group CCC(F)F CTJAKAQLCQKBTC-UHFFFAOYSA-N 0.000 description 1
OGYGFUAIIOPWQD-UHFFFAOYSA-N 1,3-thiazolidine Chemical compound C1CSCN1 OGYGFUAIIOPWQD-UHFFFAOYSA-N 0.000 description 1
CYNYIHKIEHGYOZ-UHFFFAOYSA-N 1-bromopropane Chemical compound CCCBr CYNYIHKIEHGYOZ-UHFFFAOYSA-N 0.000 description 1
MICMHFIQSAMEJG-UHFFFAOYSA-N 1-bromopyrrolidine-2,5-dione Chemical compound BrN1C(=O)CCC1=O.BrN1C(=O)CCC1=O MICMHFIQSAMEJG-UHFFFAOYSA-N 0.000 description 1
125000001478 1-chloroethyl group Chemical group [H]C([H])([H])C([H])(Cl)* 0.000 description 1
AXFOIFWQFICADV-UHFFFAOYSA-N 1-cyclopropyl-5-propylazepane-2-carboxylic acid Chemical compound C1CC(CCC)CCC(C(O)=O)N1C1CC1 AXFOIFWQFICADV-UHFFFAOYSA-N 0.000 description 1
125000004776 1-fluoroethyl group Chemical group [H]C([H])([H])C([H])(F)* 0.000 description 1
OEBXWWBYZJNKRK-UHFFFAOYSA-N 1-methyl-2,3,4,6,7,8-hexahydropyrimido[1,2-a]pyrimidine Chemical compound C1CCN=C2N(C)CCCN21 OEBXWWBYZJNKRK-UHFFFAOYSA-N 0.000 description 1
MAWGMRQFCUEYCT-UHFFFAOYSA-N 1-methyl-4-propylpyrrolidine-2-carboxylic acid Chemical compound CCCC1CC(C(O)=O)N(C)C1 MAWGMRQFCUEYCT-UHFFFAOYSA-N 0.000 description 1
UDALSWUEZBYANV-UHFFFAOYSA-N 1-methyl-n-[2-methyl-1-(3,4,5-trihydroxy-6-propan-2-ylsulfanyloxan-2-yl)propyl]-4-propylpyrrolidine-2-carboxamide Chemical compound CN1CC(CCC)CC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC(C)C)O1 UDALSWUEZBYANV-UHFFFAOYSA-N 0.000 description 1
AMMPLVWPWSYRDR-UHFFFAOYSA-N 1-methylbicyclo[2.2.2]oct-2-ene-4-carboxylic acid Chemical compound C1CC2(C(O)=O)CCC1(C)C=C2 AMMPLVWPWSYRDR-UHFFFAOYSA-N 0.000 description 1
WJFKNYWRSNBZNX-UHFFFAOYSA-N 10H-phenothiazine Chemical compound C1=CC=C2NC3=CC=CC=C3SC2=C1 WJFKNYWRSNBZNX-UHFFFAOYSA-N 0.000 description 1
TZMSYXZUNZXBOL-UHFFFAOYSA-N 10H-phenoxazine Chemical compound C1=CC=C2NC3=CC=CC=C3OC2=C1 TZMSYXZUNZXBOL-UHFFFAOYSA-N 0.000 description 1
BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical compound C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 description 1
RZYHXKLKJRGJGP-UHFFFAOYSA-N 2,2,2-trifluoro-n,n-bis(trimethylsilyl)acetamide Chemical compound C[Si](C)(C)N([Si](C)(C)C)C(=O)C(F)(F)F RZYHXKLKJRGJGP-UHFFFAOYSA-N 0.000 description 1
QLPZEDHKVHQPAD-UHFFFAOYSA-N 2,2,2-trifluoro-n-trimethylsilylacetamide Chemical compound C[Si](C)(C)NC(=O)C(F)(F)F QLPZEDHKVHQPAD-UHFFFAOYSA-N 0.000 description 1
LTMRRSWNXVJMBA-UHFFFAOYSA-L 2,2-diethylpropanedioate Chemical compound CCC(CC)(C([O-])=O)C([O-])=O LTMRRSWNXVJMBA-UHFFFAOYSA-L 0.000 description 1
KFBXYFVQCKKGSU-UHFFFAOYSA-N 2,3-dihydro-1h-isoindole Chemical compound C1=C=C[C]2CNCC2=C1 KFBXYFVQCKKGSU-UHFFFAOYSA-N 0.000 description 1
VEPOHXYIFQMVHW-XOZOLZJESA-N 2,3-dihydroxybutanedioic acid (2S,3S)-3,4-dimethyl-2-phenylmorpholine Chemical compound OC(C(O)C(O)=O)C(O)=O.C[C@H]1[C@@H](OCCN1C)c1ccccc1 VEPOHXYIFQMVHW-XOZOLZJESA-N 0.000 description 1
HLXQEJFWQGBHCX-UHFFFAOYSA-N 2-(1-aminobut-3-enyl)-6-methylsulfanyloxane-3,4,5-triol Chemical compound CSC1OC(C(N)CC=C)C(O)C(O)C1O HLXQEJFWQGBHCX-UHFFFAOYSA-N 0.000 description 1
LUMHDNNUPZAQET-UHFFFAOYSA-N 2-(bromomethyl)pent-1-ene Chemical compound CCCC(=C)CBr LUMHDNNUPZAQET-UHFFFAOYSA-N 0.000 description 1
AXHVEQQLKVIZLO-UHFFFAOYSA-N 2-[4-[2-[5-(2,2-dimethylbutyl)-1h-imidazol-2-yl]ethyl]phenyl]benzoic acid Chemical compound CCC(C)(C)CC1=CNC(CCC=2C=CC(=CC=2)C=2C(=CC=CC=2)C(O)=O)=N1 AXHVEQQLKVIZLO-UHFFFAOYSA-N 0.000 description 1
KFCSNOGWXACBOZ-UHFFFAOYSA-N 2-[[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]carbamoyl]-5-fluoro-5-propylazepane-1-carboxylic acid Chemical compound OC(=O)N1CCC(CCC)(F)CCC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(O)C(SC)O1 KFCSNOGWXACBOZ-UHFFFAOYSA-N 0.000 description 1
AUCAJTIMFQSTQV-UHFFFAOYSA-N 2-[amino(cyclopentyl)methyl]-6-methylsulfanyloxane-3,4,5-triol Chemical compound OC1C(O)C(O)C(SC)OC1C(N)C1CCCC1 AUCAJTIMFQSTQV-UHFFFAOYSA-N 0.000 description 1
ASZMNPZSGFIDKO-UHFFFAOYSA-N 2-[amino(cyclopropyl)methyl]-6-methylsulfanyloxane-3,4,5-triol Chemical compound OC1C(O)C(O)C(SC)OC1C(N)C1CC1 ASZMNPZSGFIDKO-UHFFFAOYSA-N 0.000 description 1
125000000069 2-butynyl group Chemical group [H]C([H])([H])C#CC([H])([H])* 0.000 description 1
125000001340 2-chloroethyl group Chemical group [H]C([H])(Cl)C([H])([H])* 0.000 description 1
125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 description 1
125000004791 2-fluoroethoxy group Chemical group FCCO* 0.000 description 1
125000004777 2-fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 description 1
AUVALWUPUHHNQV-UHFFFAOYSA-N 2-hydroxy-3-propylbenzoic acid Chemical class CCCC1=CC=CC(C(O)=O)=C1O AUVALWUPUHHNQV-UHFFFAOYSA-N 0.000 description 1
UPHOPMSGKZNELG-UHFFFAOYSA-N 2-hydroxynaphthalene-1-carboxylic acid Chemical group C1=CC=C2C(C(=O)O)=C(O)C=CC2=C1 UPHOPMSGKZNELG-UHFFFAOYSA-N 0.000 description 1
BXJQZHHEWYUFAC-UHFFFAOYSA-N 2-methylidenepentan-1-ol Chemical compound CCCC(=C)CO BXJQZHHEWYUFAC-UHFFFAOYSA-N 0.000 description 1
VLRSADZEDXVUPG-UHFFFAOYSA-N 2-naphthalen-1-ylpyridine Chemical compound N1=CC=CC=C1C1=CC=CC2=CC=CC=C12 VLRSADZEDXVUPG-UHFFFAOYSA-N 0.000 description 1
VSWICNJIUPRZIK-UHFFFAOYSA-N 2-piperideine Chemical compound C1CNC=CC1 VSWICNJIUPRZIK-UHFFFAOYSA-N 0.000 description 1
VHMICKWLTGFITH-UHFFFAOYSA-N 2H-isoindole Chemical compound C1=CC=CC2=CNC=C21 VHMICKWLTGFITH-UHFFFAOYSA-N 0.000 description 1
XLZYKTYMLBOINK-UHFFFAOYSA-N 3-(4-hydroxybenzoyl)benzoic acid Chemical compound OC(=O)C1=CC=CC(C(=O)C=2C=CC(O)=CC=2)=C1 XLZYKTYMLBOINK-UHFFFAOYSA-N 0.000 description 1
BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
WXXSLCUWLQKWJG-UHFFFAOYSA-N 3-butyl-n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-1-(2-hydroxyethyl)azetidine-2-carboxamide Chemical compound CCCCC1CN(CCO)C1C(=O)NC(C(C)Cl)C1C(O)C(O)C(O)C(SC)O1 WXXSLCUWLQKWJG-UHFFFAOYSA-N 0.000 description 1
FSNHRYGTEANCBQ-UHFFFAOYSA-N 3-butyl-n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-1-methylazetidine-2-carboxamide Chemical compound CCCCC1CN(C)C1C(=O)NC(C(C)Cl)C1C(O)C(O)C(O)C(SC)O1 FSNHRYGTEANCBQ-UHFFFAOYSA-N 0.000 description 1
GTOXIYGRIDEXTA-UHFFFAOYSA-N 3-butylazetidine-2-carboxylic acid Chemical compound CCCCC1CNC1C(O)=O GTOXIYGRIDEXTA-UHFFFAOYSA-N 0.000 description 1
ZRPLANDPDWYOMZ-UHFFFAOYSA-N 3-cyclopentylpropionic acid Chemical compound OC(=O)CCC1CCCC1 ZRPLANDPDWYOMZ-UHFFFAOYSA-N 0.000 description 1
IJRBTHUOKCOEQU-UHFFFAOYSA-N 3-phenyl-4-propylpyridine-2-carboxylic acid Chemical compound CCCC1=CC=NC(C(O)=O)=C1C1=CC=CC=C1 IJRBTHUOKCOEQU-UHFFFAOYSA-N 0.000 description 1
XKTYXVDYIKIYJP-UHFFFAOYSA-N 3h-dioxole Chemical compound C1OOC=C1 XKTYXVDYIKIYJP-UHFFFAOYSA-N 0.000 description 1
CBKDCOKSXCTDAA-UHFFFAOYSA-N 4,5,6,7-tetrahydro-1-benzothiophene Chemical compound C1CCCC2=C1C=CS2 CBKDCOKSXCTDAA-UHFFFAOYSA-N 0.000 description 1
VZHPFCFACVETOI-UHFFFAOYSA-N 4-(2-cyclobutylideneethyl)pyrrolidine-2-carboxylic acid Chemical compound C1NC(C(=O)O)CC1CC=C1CCC1 VZHPFCFACVETOI-UHFFFAOYSA-N 0.000 description 1
AVQLXPWGFFXNKF-UHFFFAOYSA-N 4-(3-ethoxyiminopropyl)piperidine-2-carboxylic acid Chemical compound CCON=CCCC1CCNC(C(O)=O)C1 AVQLXPWGFFXNKF-UHFFFAOYSA-N 0.000 description 1
VHDFWRRYDWHMAL-UHFFFAOYSA-N 4-(3-methoxyiminopropyl)piperidine-2-carboxylic acid Chemical compound CON=CCCC1CCNC(C(O)=O)C1 VHDFWRRYDWHMAL-UHFFFAOYSA-N 0.000 description 1
UAHGURVACUUGBB-UHFFFAOYSA-N 4-(3-thiophen-2-ylsulfanylpropyl)piperidine-2-carboxylic acid Chemical compound C1CNC(C(=O)O)CC1CCCSC1=CC=CS1 UAHGURVACUUGBB-UHFFFAOYSA-N 0.000 description 1
SZTWHSOWUZVABA-UHFFFAOYSA-N 4-[(2,4-dichlorophenyl)methylsulfanyl]-n-[2-hydroxy-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]pyrrolidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)O)NC(=O)C1NCC(SCC=2C(=CC(Cl)=CC=2)Cl)C1 SZTWHSOWUZVABA-UHFFFAOYSA-N 0.000 description 1
BFZVMDXCWJWEIG-UHFFFAOYSA-N 4-[3-(furan-2-ylmethylsulfanyl)propyl]piperidine-2-carboxylic acid Chemical compound C1CNC(C(=O)O)CC1CCCSCC1=CC=CO1 BFZVMDXCWJWEIG-UHFFFAOYSA-N 0.000 description 1
QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
WPFAQYKHMZIFSG-UHFFFAOYSA-N 4-azido-n-[2-hydroxy-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]pyrrolidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)O)NC(=O)C1NCC(N=[N+]=[N-])C1 WPFAQYKHMZIFSG-UHFFFAOYSA-N 0.000 description 1
KKPMDCGTGDKTLH-UHFFFAOYSA-N 4-butyl-n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-fluoropiperidine-2-carboxamide Chemical compound C1C(CCCC)(F)CCNC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(O)C(SC)O1 KKPMDCGTGDKTLH-UHFFFAOYSA-N 0.000 description 1
RJWBTWIBUIGANW-UHFFFAOYSA-N 4-chlorobenzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=C(Cl)C=C1 RJWBTWIBUIGANW-UHFFFAOYSA-N 0.000 description 1
VOYDLKLECKFNIY-UHFFFAOYSA-N 4-ethylsulfanylpyrrolidine-2-carboxylic acid Chemical compound CCSC1CNC(C(O)=O)C1 VOYDLKLECKFNIY-UHFFFAOYSA-N 0.000 description 1
XOJKYRONHSCESN-UHFFFAOYSA-N 4-fluoro-4-propylpiperidine-2-carboxylic acid Chemical compound CCCC1(F)CCNC(C(O)=O)C1 XOJKYRONHSCESN-UHFFFAOYSA-N 0.000 description 1
HFXAFXVXPMUQCQ-BYPYZUCNSA-N 4-oxo-L-proline Chemical compound OC(=O)[C@@H]1CC(=O)CN1 HFXAFXVXPMUQCQ-BYPYZUCNSA-N 0.000 description 1
VRJHQPZVIGNGMX-UHFFFAOYSA-N 4-piperidinone Chemical class O=C1CCNCC1 VRJHQPZVIGNGMX-UHFFFAOYSA-N 0.000 description 1
JZQCGLIVUMEIFQ-UHFFFAOYSA-N 4-propyl-n-[1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)butyl]piperidine-2-carboxamide Chemical compound O1C(SC)C(O)C(O)C(O)C1C(CCC)NC(=O)C1CC(CCC)CCN1 JZQCGLIVUMEIFQ-UHFFFAOYSA-N 0.000 description 1
IMEYTLPQQLNOOL-UHFFFAOYSA-N 4-propylpyridine-2-carbonitrile Chemical compound CCCC1=CC=NC(C#N)=C1 IMEYTLPQQLNOOL-UHFFFAOYSA-N 0.000 description 1
GDRVFDDBLLKWRI-UHFFFAOYSA-N 4H-quinolizine Chemical compound C1=CC=CN2CC=CC=C21 GDRVFDDBLLKWRI-UHFFFAOYSA-N 0.000 description 1
XDESTNYZDKFIBW-UHFFFAOYSA-N 5-(cyclopropylmethyl)-1-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]azepane-2-carboxylic acid Chemical compound O1C(=O)OC(CN2C(CCC(CC3CC3)CC2)C(O)=O)=C1C XDESTNYZDKFIBW-UHFFFAOYSA-N 0.000 description 1
JDQDZTGYGGLFCZ-UHFFFAOYSA-N 5-cyclopropylazepane-2-carboxylic acid Chemical compound C1CNC(C(=O)O)CCC1C1CC1 JDQDZTGYGGLFCZ-UHFFFAOYSA-N 0.000 description 1
MIXWHUXPUGYMQX-UHFFFAOYSA-N 5-ethylazepane-2-carboxylic acid Chemical compound CCC1CCNC(C(O)=O)CC1 MIXWHUXPUGYMQX-UHFFFAOYSA-N 0.000 description 1
ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
244000215068 Acacia senegal Species 0.000 description 1
235000006491 Acacia senegal Nutrition 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
241000416162 Astragalus gummifer Species 0.000 description 1
239000005711 Benzoic acid Substances 0.000 description 1
POIVICPLCYEACF-UHFFFAOYSA-N C1CC1C=C=CC1CCCCC1 Chemical group C1CC1C=C=CC1CCCCC1 POIVICPLCYEACF-UHFFFAOYSA-N 0.000 description 1
UYELPCHKSYWACL-UHFFFAOYSA-N C=C(CCOS(=O)(=O)CC1=CC=CC=C1)CCC Chemical compound C=C(CCOS(=O)(=O)CC1=CC=CC=C1)CCC UYELPCHKSYWACL-UHFFFAOYSA-N 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
241000222120 Candida <Saccharomycetales> Species 0.000 description 1
241000222122 Candida albicans Species 0.000 description 1
WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
PTHCMJGKKRQCBF-UHFFFAOYSA-N Cellulose, microcrystalline Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC)C(CO)O1 PTHCMJGKKRQCBF-UHFFFAOYSA-N 0.000 description 1
229910021595 Copper(I) iodide Inorganic materials 0.000 description 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Chemical group OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
238000006236 Dondoni homologation reaction Methods 0.000 description 1
GYCKQBWUSACYIF-UHFFFAOYSA-N Ethyl salicylate Chemical compound CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 description 1
KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Chemical group OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
229920000084 Gum arabic Polymers 0.000 description 1
229910004373 HOAc Inorganic materials 0.000 description 1
PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
WRYCSMQKUKOKBP-UHFFFAOYSA-N Imidazolidine Chemical compound C1CNCN1 WRYCSMQKUKOKBP-UHFFFAOYSA-N 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical group OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
229930182821 L-proline Natural products 0.000 description 1
229910010084 LiAlH4 Inorganic materials 0.000 description 1
229930195725 Mannitol Natural products 0.000 description 1
239000012359 Methanesulfonyl chloride Substances 0.000 description 1
TXXHDPDFNKHHGW-CCAGOZQPSA-N Muconic acid Chemical group OC(=O)\C=C/C=C\C(O)=O TXXHDPDFNKHHGW-CCAGOZQPSA-N 0.000 description 1
241000235395 Mucor Species 0.000 description 1
241000235526 Mucor racemosus Species 0.000 description 1
235000009421 Myristica fragrans Nutrition 0.000 description 1
MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
235000019483 Peanut oil Nutrition 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 1
CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
229920001800 Shellac Polymers 0.000 description 1
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 1
KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
238000006859 Swern oxidation reaction Methods 0.000 description 1
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
229920001615 Tragacanth Polymers 0.000 description 1
GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
241000748245 Villanova Species 0.000 description 1
238000007295 Wittig olefination reaction Methods 0.000 description 1
DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
PXVYKHUQICALGJ-UHFFFAOYSA-L [Cs+].[Cs+].[O-]C([O-])=O.CCN(CC)CC Chemical compound [Cs+].[Cs+].[O-]C([O-])=O.CCN(CC)CC PXVYKHUQICALGJ-UHFFFAOYSA-L 0.000 description 1
SORGEQQSQGNZFI-UHFFFAOYSA-N [azido(phenoxy)phosphoryl]oxybenzene Chemical compound C=1C=CC=CC=1OP(=O)(N=[N+]=[N-])OC1=CC=CC=C1 SORGEQQSQGNZFI-UHFFFAOYSA-N 0.000 description 1
235000010489 acacia gum Nutrition 0.000 description 1
DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
150000001241 acetals Chemical class 0.000 description 1
PWQLZSHJRGGLBC-UHFFFAOYSA-N acetonitrile;carbon dioxide Chemical compound CC#N.O=C=O PWQLZSHJRGGLBC-UHFFFAOYSA-N 0.000 description 1
125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
229940081735 acetylcellulose Drugs 0.000 description 1
150000008065 acid anhydrides Chemical class 0.000 description 1
ODHCTXKNWHHXJC-UHFFFAOYSA-N acide pyroglutamique Natural products OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 description 1
239000003929 acidic solution Substances 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
230000009471 action Effects 0.000 description 1
239000011149 active material Substances 0.000 description 1
230000002411 adverse Effects 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
238000002814 agar dilution Methods 0.000 description 1
238000013019 agitation Methods 0.000 description 1
235000010443 alginic acid Nutrition 0.000 description 1
229920000615 alginic acid Polymers 0.000 description 1
239000003513 alkali Substances 0.000 description 1
229910001413 alkali metal ion Inorganic materials 0.000 description 1
229910001420 alkaline earth metal ion Inorganic materials 0.000 description 1
150000001345 alkine derivatives Chemical class 0.000 description 1
150000001347 alkyl bromides Chemical class 0.000 description 1
BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 1
RMRFFCXPLWYOOY-UHFFFAOYSA-N allyl radical Chemical compound [CH2]C=C RMRFFCXPLWYOOY-UHFFFAOYSA-N 0.000 description 1
HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
125000000266 alpha-aminoacyl group Chemical group 0.000 description 1
BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
229910052782 aluminium Inorganic materials 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
210000003484 anatomy Anatomy 0.000 description 1
125000005428 anthryl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C3C(*)=C([H])C([H])=C([H])C3=C([H])C2=C1[H] 0.000 description 1
229940124350 antibacterial drug Drugs 0.000 description 1
238000009635 antibiotic susceptibility testing Methods 0.000 description 1
239000003125 aqueous solvent Substances 0.000 description 1
239000007900 aqueous suspension Substances 0.000 description 1
229910052786 argon Inorganic materials 0.000 description 1
HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 description 1
125000002393 azetidinyl group Chemical group 0.000 description 1
SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
229940092714 benzenesulfonic acid Drugs 0.000 description 1
MYONAGGJKCJOBT-UHFFFAOYSA-N benzimidazol-2-one Chemical compound C1=CC=CC2=NC(=O)N=C21 MYONAGGJKCJOBT-UHFFFAOYSA-N 0.000 description 1
125000005605 benzo group Chemical group 0.000 description 1
235000010233 benzoic acid Nutrition 0.000 description 1
MJSHDCCLFGOEIK-UHFFFAOYSA-N benzyl (2,5-dioxopyrrolidin-1-yl) carbonate Chemical compound O=C1CCC(=O)N1OC(=O)OCC1=CC=CC=C1 MJSHDCCLFGOEIK-UHFFFAOYSA-N 0.000 description 1
GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 1
FCDPQMAOJARMTG-UHFFFAOYSA-L benzylidene-[1,3-bis(2,4,6-trimethylphenyl)imidazolidin-2-ylidene]-dichlororuthenium;tricyclohexylphosphane Chemical compound C1CCCCC1P(C1CCCCC1)C1CCCCC1.CC1=CC(C)=CC(C)=C1N(CCN1C=2C(=CC(C)=CC=2C)C)C1=[Ru](Cl)(Cl)=CC1=CC=CC=C1 FCDPQMAOJARMTG-UHFFFAOYSA-L 0.000 description 1
125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
239000003181 biological factor Substances 0.000 description 1
230000001851 biosynthetic effect Effects 0.000 description 1
SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
230000036765 blood level Effects 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
125000001246 bromo group Chemical group Br* 0.000 description 1
239000001273 butane Substances 0.000 description 1
KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
239000006227 byproduct Substances 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
235000001465 calcium Nutrition 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
229940095731 candida albicans Drugs 0.000 description 1
150000004657 carbamic acid derivatives Chemical class 0.000 description 1
150000001722 carbon compounds Chemical class 0.000 description 1
150000007942 carboxylates Chemical class 0.000 description 1
229920002301 cellulose acetate Polymers 0.000 description 1
210000004289 cerebral ventricle Anatomy 0.000 description 1
229960000541 cetyl alcohol Drugs 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
239000007810 chemical reaction solvent Substances 0.000 description 1
238000010568 chiral column chromatography Methods 0.000 description 1
208000028512 chlamydia infectious disease Diseases 0.000 description 1
239000012320 chlorinating reagent Substances 0.000 description 1
150000001805 chlorine compounds Chemical class 0.000 description 1
IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 1
VZWXIQHBIQLMPN-UHFFFAOYSA-N chromane Chemical compound C1=CC=C2CCCOC2=C1 VZWXIQHBIQLMPN-UHFFFAOYSA-N 0.000 description 1
WCZVZNOTHYJIEI-UHFFFAOYSA-N cinnoline Chemical compound N1=NC=CC2=CC=CC=C21 WCZVZNOTHYJIEI-UHFFFAOYSA-N 0.000 description 1
238000000576 coating method Methods 0.000 description 1
239000003240 coconut oil Substances 0.000 description 1
235000019864 coconut oil Nutrition 0.000 description 1
229940075614 colloidal silicon dioxide Drugs 0.000 description 1
239000000084 colloidal system Substances 0.000 description 1
230000001332 colony forming effect Effects 0.000 description 1
238000004891 communication Methods 0.000 description 1
229940125904 compound 1 Drugs 0.000 description 1
238000010276 construction Methods 0.000 description 1
238000011109 contamination Methods 0.000 description 1
LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 1
239000006184 cosolvent Substances 0.000 description 1
235000012343 cottonseed oil Nutrition 0.000 description 1
239000002385 cottonseed oil Substances 0.000 description 1
125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
238000006115 defluorination reaction Methods 0.000 description 1
238000011161 development Methods 0.000 description 1
239000008121 dextrose Substances 0.000 description 1
AZSZCFSOHXEJQE-UHFFFAOYSA-N dibromodifluoromethane Chemical compound FC(F)(Br)Br AZSZCFSOHXEJQE-UHFFFAOYSA-N 0.000 description 1
LTUTVFXOEGMHMP-UHFFFAOYSA-N dibromofluoromethane Chemical compound FC(Br)Br LTUTVFXOEGMHMP-UHFFFAOYSA-N 0.000 description 1
ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
NNDOHYGFLASMFR-UHFFFAOYSA-N diethyl 2,2-dipropylpropanedioate Chemical compound CCOC(=O)C(CCC)(CCC)C(=O)OCC NNDOHYGFLASMFR-UHFFFAOYSA-N 0.000 description 1
HQWPLXHWEZZGKY-UHFFFAOYSA-N diethylzinc Chemical compound CC[Zn]CC HQWPLXHWEZZGKY-UHFFFAOYSA-N 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
MKRTXPORKIRPDG-UHFFFAOYSA-N diphenylphosphoryl azide Chemical compound C=1C=CC=CC=1P(=O)(N=[N+]=[N-])C1=CC=CC=C1 MKRTXPORKIRPDG-UHFFFAOYSA-N 0.000 description 1
KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
239000006185 dispersion Substances 0.000 description 1
238000004821 distillation Methods 0.000 description 1
MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical group CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
231100000673 dose–response relationship Toxicity 0.000 description 1
238000007876 drug discovery Methods 0.000 description 1
229940112141 dry powder inhaler Drugs 0.000 description 1
210000001198 duodenum Anatomy 0.000 description 1
239000008157 edible vegetable oil Substances 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
230000001804 emulsifying effect Effects 0.000 description 1
238000005837 enolization reaction Methods 0.000 description 1
239000002702 enteric coating Substances 0.000 description 1
CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
150000002170 ethers Chemical class 0.000 description 1
MXUMJFMINXROCH-UHFFFAOYSA-N ethyl 2-methylidenepentanoate Chemical compound CCCC(=C)C(=O)OCC MXUMJFMINXROCH-UHFFFAOYSA-N 0.000 description 1
239000002024 ethyl acetate extract Substances 0.000 description 1
125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
239000012054 flavored emulsion Substances 0.000 description 1
235000020375 flavoured syrup Nutrition 0.000 description 1
150000002222 fluorine compounds Chemical class 0.000 description 1
239000006260 foam Substances 0.000 description 1
235000013355 food flavoring agent Nutrition 0.000 description 1
235000003599 food sweetener Nutrition 0.000 description 1
239000001530 fumaric acid Substances 0.000 description 1
235000011087 fumaric acid Nutrition 0.000 description 1
150000002243 furanoses Chemical class 0.000 description 1
150000008195 galaktosides Chemical class 0.000 description 1
239000007789 gas Substances 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
239000000174 gluconic acid Chemical group 0.000 description 1
235000012208 gluconic acid Nutrition 0.000 description 1
239000004220 glutamic acid Chemical group 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
BEBCJVAWIBVWNZ-UHFFFAOYSA-N glycinamide Chemical compound NCC(N)=O BEBCJVAWIBVWNZ-UHFFFAOYSA-N 0.000 description 1
150000004820 halides Chemical class 0.000 description 1
230000026030 halogenation Effects 0.000 description 1
238000005658 halogenation reaction Methods 0.000 description 1
238000003306 harvesting Methods 0.000 description 1
230000036541 health Effects 0.000 description 1
UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Chemical class C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 1
239000008240 homogeneous mixture Substances 0.000 description 1
XPXMKIXDFWLRAA-UHFFFAOYSA-N hydrazinide Chemical compound [NH-]N XPXMKIXDFWLRAA-UHFFFAOYSA-N 0.000 description 1
BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical class [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
230000003301 hydrolyzing effect Effects 0.000 description 1
RGZRSLKIOCHTSI-UHFFFAOYSA-N hydron;n-methylhydroxylamine;chloride Chemical compound Cl.CNO RGZRSLKIOCHTSI-UHFFFAOYSA-N 0.000 description 1
XNXVOSBNFZWHBV-UHFFFAOYSA-N hydron;o-methylhydroxylamine;chloride Chemical compound Cl.CON XNXVOSBNFZWHBV-UHFFFAOYSA-N 0.000 description 1
XXROGKLTLUQVRX-UHFFFAOYSA-N hydroxymethylethylene Natural products OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 description 1
239000000819 hypertonic solution Substances 0.000 description 1
229940021223 hypertonic solution Drugs 0.000 description 1
MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
238000010874 in vitro model Methods 0.000 description 1
PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
LPAGFVYQRIESJQ-UHFFFAOYSA-N indoline Chemical compound C1=CC=C2NCCC2=C1 LPAGFVYQRIESJQ-UHFFFAOYSA-N 0.000 description 1
HOBCFUWDNJPFHB-UHFFFAOYSA-N indolizine Chemical compound C1=CC=CN2C=CC=C21 HOBCFUWDNJPFHB-UHFFFAOYSA-N 0.000 description 1
239000011261 inert gas Substances 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
238000001361 intraarterial administration Methods 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
125000002346 iodo group Chemical group I* 0.000 description 1
125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
HEBMCVBCEDMUOF-UHFFFAOYSA-N isochromane Chemical compound C1=CC=C2COCCC2=C1 HEBMCVBCEDMUOF-UHFFFAOYSA-N 0.000 description 1
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
ZLTPDFXIESTBQG-UHFFFAOYSA-N isothiazole Chemical compound C=1C=NSC=1 ZLTPDFXIESTBQG-UHFFFAOYSA-N 0.000 description 1
CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 1
239000004310 lactic acid Substances 0.000 description 1
235000014655 lactic acid Nutrition 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
229940041028 lincosamides Drugs 0.000 description 1
150000002632 lipids Chemical class 0.000 description 1
239000011344 liquid material Substances 0.000 description 1
239000012280 lithium aluminium hydride Substances 0.000 description 1
LZWQNOHZMQIFBX-UHFFFAOYSA-N lithium;2-methylpropan-2-olate Chemical compound [Li+].CC(C)(C)[O-] LZWQNOHZMQIFBX-UHFFFAOYSA-N 0.000 description 1
244000144972 livestock Species 0.000 description 1
239000007937 lozenge Substances 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
239000001115 mace Substances 0.000 description 1
CCERQOYLJJULMD-UHFFFAOYSA-M magnesium;carbanide;chloride Chemical compound [CH3-].[Mg+2].[Cl-] CCERQOYLJJULMD-UHFFFAOYSA-M 0.000 description 1
230000014759 maintenance of location Effects 0.000 description 1
201000004792 malaria Diseases 0.000 description 1
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
239000011976 maleic acid Substances 0.000 description 1
239000001630 malic acid Substances 0.000 description 1
235000011090 malic acid Nutrition 0.000 description 1
229960002510 mandelic acid Drugs 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
229910052753 mercury Inorganic materials 0.000 description 1
229910021645 metal ion Inorganic materials 0.000 description 1
238000005649 metathesis reaction Methods 0.000 description 1
229920000609 methyl cellulose Polymers 0.000 description 1
239000001923 methylcellulose Substances 0.000 description 1
235000010981 methylcellulose Nutrition 0.000 description 1
244000005700 microbiome Species 0.000 description 1
238000003801 milling Methods 0.000 description 1
150000007522 mineralic acids Chemical class 0.000 description 1
238000002156 mixing Methods 0.000 description 1
SFDZETWZUCDYMD-UHFFFAOYSA-N monosodium acetylide Chemical compound [Na+].[C-]#C SFDZETWZUCDYMD-UHFFFAOYSA-N 0.000 description 1
125000002757 morpholinyl group Chemical group 0.000 description 1
239000012452 mother liquor Substances 0.000 description 1
NCGWKCHAJOUDHQ-UHFFFAOYSA-N n,n-diethylethanamine;formic acid Chemical compound OC=O.OC=O.CCN(CC)CC NCGWKCHAJOUDHQ-UHFFFAOYSA-N 0.000 description 1
KYGJZIHIPWUWKP-UHFFFAOYSA-N n-[(4-chlorophenyl)-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)methyl]-1-methyl-4-propylpyrrolidine-2-carboxamide Chemical compound CN1CC(CCC)CC1C(=O)NC(C=1C=CC(Cl)=CC=1)C1C(O)C(O)C(O)C(SC)O1 KYGJZIHIPWUWKP-UHFFFAOYSA-N 0.000 description 1
FNPXAEAJOCLTEZ-UHFFFAOYSA-N n-[(4-chlorophenyl)-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)methyl]-4-propylpiperidine-2-carboxamide Chemical compound C1C(CCC)CCNC1C(=O)NC(C=1C=CC(Cl)=CC=1)C1C(O)C(O)C(O)C(SC)O1 FNPXAEAJOCLTEZ-UHFFFAOYSA-N 0.000 description 1
GUDVDKMDLVTWRX-UHFFFAOYSA-N n-[(4-chlorophenyl)-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)methyl]-5-propylazepane-2-carboxamide Chemical compound C1CC(CCC)CCNC1C(=O)NC(C=1C=CC(Cl)=CC=1)C1C(O)C(O)C(O)C(SC)O1 GUDVDKMDLVTWRX-UHFFFAOYSA-N 0.000 description 1
ZLAOMJXXIMXPFT-UHFFFAOYSA-N n-[1-(6-tert-butylsulfanyl-3,4,5-trihydroxyoxan-2-yl)-2-methylpropyl]-1-methyl-4-propylpyrrolidine-2-carboxamide Chemical compound CN1CC(CCC)CC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC(C)(C)C)O1 ZLAOMJXXIMXPFT-UHFFFAOYSA-N 0.000 description 1
OJGIIFXADWWGJL-UHFFFAOYSA-N n-[1-(6-tert-butylsulfanyl-3,4,5-trihydroxyoxan-2-yl)-2-methylpropyl]-4-propylpiperidine-2-carboxamide Chemical compound C1C(CCC)CCNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC(C)(C)C)O1 OJGIIFXADWWGJL-UHFFFAOYSA-N 0.000 description 1
XDKJWJSGKHLPHF-UHFFFAOYSA-N n-[1-[6-(2-ethoxyethyl)-3,4,5-trihydroxyoxan-2-yl]-2-methylpropyl]-4-pentylpyrrolidine-2-carboxamide Chemical compound C1C(CCCCC)CNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(CCOCC)O1 XDKJWJSGKHLPHF-UHFFFAOYSA-N 0.000 description 1
XLNNBHCKTXTCIT-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-3-(2-cyclobutylethyl)azetidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)Cl)NC(=O)C1C(CCC2CCC2)CN1 XLNNBHCKTXTCIT-UHFFFAOYSA-N 0.000 description 1
XDLPJKNAUSHXKC-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-3-(2-cyclopropylethyl)azetidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)Cl)NC(=O)C1C(CCC2CC2)CN1 XDLPJKNAUSHXKC-UHFFFAOYSA-N 0.000 description 1
ZRFLECCTJLQRPR-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-3-(3,3-difluoropropyl)azetidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)Cl)NC(=O)C1C(CCC(F)F)CN1 ZRFLECCTJLQRPR-UHFFFAOYSA-N 0.000 description 1
JDJBGDJTWVWKGG-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-3-(3-cyclopropylpropyl)azetidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)Cl)NC(=O)C1C(CCCC2CC2)CN1 JDJBGDJTWVWKGG-UHFFFAOYSA-N 0.000 description 1
OCNIGBIKASAIRC-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-3-(3-methylbutyl)azetidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)Cl)NC(=O)C1C(CCC(C)C)CN1 OCNIGBIKASAIRC-UHFFFAOYSA-N 0.000 description 1
JPOPDFDIUYRCJS-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-3-pentylazetidine-2-carboxamide Chemical compound CCCCCC1CNC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(O)C(SC)O1 JPOPDFDIUYRCJS-UHFFFAOYSA-N 0.000 description 1
JJLGDBJIQCVHAU-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-(2-cyclobutylethyl)piperidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)Cl)NC(=O)C1NCCC(CCC2CCC2)C1 JJLGDBJIQCVHAU-UHFFFAOYSA-N 0.000 description 1
VHDZVMQUPLNISA-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-(2-cyclobutylethyl)pyrrolidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)Cl)NC(=O)C1NCC(CCC2CCC2)C1 VHDZVMQUPLNISA-UHFFFAOYSA-N 0.000 description 1
SRVZSYVCSMVUNJ-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-(2-cyclobutylideneethyl)pyrrolidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)Cl)NC(=O)C1NCC(CC=C2CCC2)C1 SRVZSYVCSMVUNJ-UHFFFAOYSA-N 0.000 description 1
PNCFHBJDSKAXBS-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-(2-cyclopropylethyl)pyrrolidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)Cl)NC(=O)C1NCC(CCC2CC2)C1 PNCFHBJDSKAXBS-UHFFFAOYSA-N 0.000 description 1
AHKWANGDKVXLJO-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-(cyclobutylmethyl)piperidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)Cl)NC(=O)C1NCCC(CC2CCC2)C1 AHKWANGDKVXLJO-UHFFFAOYSA-N 0.000 description 1
XMTAUQGPNDCSKR-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-(cyclopropylmethyl)-4-fluoropiperidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)Cl)NC(=O)C1NCCC(F)(CC2CC2)C1 XMTAUQGPNDCSKR-UHFFFAOYSA-N 0.000 description 1
LBEISHXSIBIHME-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-(cyclopropylmethyl)piperidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)Cl)NC(=O)C1NCCC(CC2CC2)C1 LBEISHXSIBIHME-UHFFFAOYSA-N 0.000 description 1
QDEOIFYJYVIITD-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-(cyclopropylmethyl)pyrrolidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)Cl)NC(=O)C1NCC(CC2CC2)C1 QDEOIFYJYVIITD-UHFFFAOYSA-N 0.000 description 1
DLPDEOJDPWNYGU-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-ethyl-4-fluoropiperidine-2-carboxamide Chemical compound C1C(CC)(F)CCNC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(O)C(SC)O1 DLPDEOJDPWNYGU-UHFFFAOYSA-N 0.000 description 1
GXCCJSBRRHOFPR-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-ethyl-5-methylazepane-2-carboxamide Chemical compound N1CCC(C)C(CC)CC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(O)C(SC)O1 GXCCJSBRRHOFPR-UHFFFAOYSA-N 0.000 description 1
OFGBGSARZVYJST-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-propylazepane-2-carboxamide Chemical compound C1C(CCC)CCCNC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(O)C(SC)O1 OFGBGSARZVYJST-UHFFFAOYSA-N 0.000 description 1
LFAIRROQEQNGKW-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-5-(cyclopropylmethyl)azepane-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)Cl)NC(=O)C1NCCC(CC2CC2)CC1 LFAIRROQEQNGKW-UHFFFAOYSA-N 0.000 description 1
ACLQIUGLPHLMNV-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-5-ethyl-4-methylazepane-2-carboxamide Chemical compound C1C(C)C(CC)CCNC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(O)C(SC)O1 ACLQIUGLPHLMNV-UHFFFAOYSA-N 0.000 description 1
QUFFGAFHMJTPCB-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-5-fluoro-5-propylazepane-2-carboxamide Chemical compound C1CC(CCC)(F)CCNC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(O)C(SC)O1 QUFFGAFHMJTPCB-UHFFFAOYSA-N 0.000 description 1
JLZWBUFHJLMTDC-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-5-methylazepane-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)Cl)NC(=O)C1NCCC(C)CC1 JLZWBUFHJLMTDC-UHFFFAOYSA-N 0.000 description 1
KWAVCLCNECFROS-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-5-propylazepane-2-carboxamide Chemical compound C1CC(CCC)CCNC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(O)C(SC)O1 KWAVCLCNECFROS-UHFFFAOYSA-N 0.000 description 1
JSOJXRFXOZYQQY-UHFFFAOYSA-N n-[cyclopentyl-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)methyl]-4-propylpiperidine-2-carboxamide Chemical compound C1C(CCC)CCNC1C(=O)NC(C1C(C(O)C(O)C(SC)O1)O)C1CCCC1 JSOJXRFXOZYQQY-UHFFFAOYSA-N 0.000 description 1
SDSSYLGILMURIY-UHFFFAOYSA-N n-[cyclopentyl-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)methyl]-5-propylazepane-2-carboxamide Chemical compound C1CC(CCC)CCNC1C(=O)NC(C1C(C(O)C(O)C(SC)O1)O)C1CCCC1 SDSSYLGILMURIY-UHFFFAOYSA-N 0.000 description 1
GSFQJVMELLKQFD-UHFFFAOYSA-N n-[cyclopropyl-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)methyl]-5-propylazepane-2-carboxamide Chemical compound C1CC(CCC)CCNC1C(=O)NC(C1C(C(O)C(O)C(SC)O1)O)C1CC1 GSFQJVMELLKQFD-UHFFFAOYSA-N 0.000 description 1
RTOCJIWYFOYZQQ-UHFFFAOYSA-N n-[phenyl-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)methyl]-4-propylpiperidine-2-carboxamide Chemical compound C1C(CCC)CCNC1C(=O)NC(C=1C=CC=CC=1)C1C(O)C(O)C(O)C(SC)O1 RTOCJIWYFOYZQQ-UHFFFAOYSA-N 0.000 description 1
125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
SQDFHQJTAWCFIB-UHFFFAOYSA-N n-methylidenehydroxylamine Chemical compound ON=C SQDFHQJTAWCFIB-UHFFFAOYSA-N 0.000 description 1
KVBGVZZKJNLNJU-UHFFFAOYSA-N naphthalene-2-sulfonic acid Chemical compound C1=CC=CC2=CC(S(=O)(=O)O)=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-N 0.000 description 1
125000001624 naphthyl group Chemical group 0.000 description 1
229910017604 nitric acid Inorganic materials 0.000 description 1
125000004433 nitrogen atom Chemical group N* 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
231100000956 nontoxicity Toxicity 0.000 description 1
239000012434 nucleophilic reagent Substances 0.000 description 1
239000012053 oil suspension Substances 0.000 description 1
239000002674 ointment Substances 0.000 description 1
238000006772 olefination reaction Methods 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
235000005985 organic acids Nutrition 0.000 description 1
238000006053 organic reaction Methods 0.000 description 1
ATYBXHSAIOKLMG-UHFFFAOYSA-N oxepin Chemical compound O1C=CC=CC=C1 ATYBXHSAIOKLMG-UHFFFAOYSA-N 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
230000001590 oxidative effect Effects 0.000 description 1
150000002924 oxiranes Chemical class 0.000 description 1
LVSJDHGRKAEGLX-UHFFFAOYSA-N oxolane;2,2,2-trifluoroacetic acid Chemical compound C1CCOC1.OC(=O)C(F)(F)F LVSJDHGRKAEGLX-UHFFFAOYSA-N 0.000 description 1
125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Chemical group OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
239000000312 peanut oil Substances 0.000 description 1
125000004115 pentoxy group Chemical group [*]OC([H])([H])C([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
230000000737 periodic effect Effects 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
229950000688 phenothiazine Drugs 0.000 description 1
ACVYVLVWPXVTIT-UHFFFAOYSA-N phosphinic acid Chemical compound O[PH2]=O ACVYVLVWPXVTIT-UHFFFAOYSA-N 0.000 description 1
UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 1
SFLGSKRGOWRGBR-UHFFFAOYSA-N phthalane Chemical compound C1=CC=C2COCC2=C1 SFLGSKRGOWRGBR-UHFFFAOYSA-N 0.000 description 1
LFSXCDWNBUNEEM-UHFFFAOYSA-N phthalazine Chemical compound C1=NN=CC2=CC=CC=C21 LFSXCDWNBUNEEM-UHFFFAOYSA-N 0.000 description 1
XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 1
229940081066 picolinic acid Drugs 0.000 description 1
125000003386 piperidinyl group Chemical group 0.000 description 1
229960005235 piperonyl butoxide Drugs 0.000 description 1
IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
230000036470 plasma concentration Effects 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
239000011591 potassium Substances 0.000 description 1
235000015320 potassium carbonate Nutrition 0.000 description 1
235000003270 potassium fluoride Nutrition 0.000 description 1
239000011698 potassium fluoride Substances 0.000 description 1
LJCNRYVRMXRIQR-OLXYHTOASA-L potassium sodium L-tartrate Chemical compound [Na+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O LJCNRYVRMXRIQR-OLXYHTOASA-L 0.000 description 1
WSHYKIAQCMIPTB-UHFFFAOYSA-M potassium;2-oxo-3-(3-oxo-1-phenylbutyl)chromen-4-olate Chemical compound [K+].[O-]C=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 WSHYKIAQCMIPTB-UHFFFAOYSA-M 0.000 description 1
238000002953 preparative HPLC Methods 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
238000011321 prophylaxis Methods 0.000 description 1
235000019260 propionic acid Nutrition 0.000 description 1
125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
239000003586 protic polar solvent Substances 0.000 description 1
CPNGPNLZQNNVQM-UHFFFAOYSA-N pteridine Chemical compound N1=CN=CC2=NC=CN=C21 CPNGPNLZQNNVQM-UHFFFAOYSA-N 0.000 description 1
230000000541 pulsatile effect Effects 0.000 description 1
239000008213 purified water Substances 0.000 description 1
150000003214 pyranose derivatives Chemical class 0.000 description 1
PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 1
229940107700 pyruvic acid Drugs 0.000 description 1
230000000171 quenching effect Effects 0.000 description 1
JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 description 1
IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
238000001953 recrystallisation Methods 0.000 description 1
238000011160 research Methods 0.000 description 1
239000013557 residual solvent Substances 0.000 description 1
230000000241 respiratory effect Effects 0.000 description 1
230000029058 respiratory gaseous exchange Effects 0.000 description 1
230000004044 response Effects 0.000 description 1
238000002390 rotary evaporation Methods 0.000 description 1
102220007331 rs111033633 Human genes 0.000 description 1
VGGUKFAVHPGNBF-UHFFFAOYSA-N s-ethyl 2,2,2-trifluoroethanethioate Chemical compound CCSC(=O)C(F)(F)F VGGUKFAVHPGNBF-UHFFFAOYSA-N 0.000 description 1
229960004889 salicylic acid Drugs 0.000 description 1
229930195734 saturated hydrocarbon Natural products 0.000 description 1
125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
150000003335 secondary amines Chemical class 0.000 description 1
239000012056 semi-solid material Substances 0.000 description 1
239000008159 sesame oil Substances 0.000 description 1
235000011803 sesame oil Nutrition 0.000 description 1
239000004208 shellac Substances 0.000 description 1
ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
229940113147 shellac Drugs 0.000 description 1
235000013874 shellac Nutrition 0.000 description 1
CQLFBEKRDQMJLZ-UHFFFAOYSA-M silver acetate Chemical compound [Ag+].CC([O-])=O CQLFBEKRDQMJLZ-UHFFFAOYSA-M 0.000 description 1
239000001632 sodium acetate Substances 0.000 description 1
235000017281 sodium acetate Nutrition 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
239000001476 sodium potassium tartrate Substances 0.000 description 1
235000011006 sodium potassium tartrate Nutrition 0.000 description 1
239000011343 solid material Substances 0.000 description 1
239000000600 sorbitol Substances 0.000 description 1
235000010356 sorbitol Nutrition 0.000 description 1
230000003595 spectral effect Effects 0.000 description 1
239000012058 sterile packaged powder Substances 0.000 description 1
210000002784 stomach Anatomy 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
229960002317 succinimide Drugs 0.000 description 1
125000002653 sulfanylmethyl group Chemical group [H]SC([H])([H])[*] 0.000 description 1
125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 1
229940124530 sulfonamide Drugs 0.000 description 1
150000003456 sulfonamides Chemical class 0.000 description 1
150000003457 sulfones Chemical group 0.000 description 1
150000003462 sulfoxides Chemical class 0.000 description 1
235000011149 sulphuric acid Nutrition 0.000 description 1
239000000375 suspending agent Substances 0.000 description 1
230000002459 sustained effect Effects 0.000 description 1
239000003765 sweetening agent Substances 0.000 description 1
230000009885 systemic effect Effects 0.000 description 1
239000007916 tablet composition Substances 0.000 description 1
239000011975 tartaric acid Substances 0.000 description 1
235000002906 tartaric acid Nutrition 0.000 description 1
RUPAXCPQAAOIPB-UHFFFAOYSA-N tert-butyl formate Chemical compound CC(C)(C)OC=O RUPAXCPQAAOIPB-UHFFFAOYSA-N 0.000 description 1
ZYDKYFIXEYSNPO-UHFFFAOYSA-N tert-butyl-dimethyl-prop-2-ynoxysilane Chemical compound CC(C)(C)[Si](C)(C)OCC#C ZYDKYFIXEYSNPO-UHFFFAOYSA-N 0.000 description 1
238000012956 testing procedure Methods 0.000 description 1
JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 description 1
125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
231100001274 therapeutic index Toxicity 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
229930192474 thiophene Natural products 0.000 description 1
230000000699 topical effect Effects 0.000 description 1
239000012049 topical pharmaceutical composition Substances 0.000 description 1
125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
235000010487 tragacanth Nutrition 0.000 description 1
239000000196 tragacanth Substances 0.000 description 1
229940116362 tragacanth Drugs 0.000 description 1
230000037317 transdermal delivery Effects 0.000 description 1
238000000844 transformation Methods 0.000 description 1
150000003852 triazoles Chemical class 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
PBIMIGNDTBRRPI-UHFFFAOYSA-N trifluoro borate Chemical compound FOB(OF)OF PBIMIGNDTBRRPI-UHFFFAOYSA-N 0.000 description 1
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
WVLBCYQITXONBZ-UHFFFAOYSA-N trimethyl phosphate Chemical compound COP(=O)(OC)OC WVLBCYQITXONBZ-UHFFFAOYSA-N 0.000 description 1
HYWCXWRMUZYRPH-UHFFFAOYSA-N trimethyl(prop-2-enyl)silane Chemical compound C[Si](C)(C)CC=C HYWCXWRMUZYRPH-UHFFFAOYSA-N 0.000 description 1
CMSYDJVRTHCWFP-UHFFFAOYSA-N triphenylphosphane;hydrobromide Chemical compound Br.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 CMSYDJVRTHCWFP-UHFFFAOYSA-N 0.000 description 1
238000009827 uniform distribution Methods 0.000 description 1
239000003981 vehicle Substances 0.000 description 1
229920002554 vinyl polymer Polymers 0.000 description 1
238000010792 warming Methods 0.000 description 1
239000003643 water by type Substances 0.000 description 1
239000000080 wetting agent Substances 0.000 description 1
150000003952 β-lactams Chemical class 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/14—Acyclic radicals, not substituted by cyclic structures attached to a sulfur, selenium or tellurium atom of a saccharide radical
- C07H15/16—Lincomycin; Derivatives thereof

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Epidemiology (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Crystallography & Structural Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

OA1200500364A 2003-06-17 2004-06-17 Novel lincomycin derivatives possessing antimicrobial activity. OA13179A (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US47929603P	2003-06-17	2003-06-17
US47950203P	2003-06-17	2003-06-17
US10/642,807 US7164011B2 (en)	2002-08-15	2003-08-15	Lincomycin derivatives possessing antibacterial activity
US10/777,455 US7199105B2 (en)	2002-08-15	2004-02-11	Lincomycin derivatives possessing antibacterial activity

Publications (1)

Publication Number	Publication Date
OA13179A true OA13179A (en)	2006-12-13

Family

ID=40203032

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
OA1200500364A OA13179A (en)	2003-06-17	2004-06-17	Novel lincomycin derivatives possessing antimicrobial activity.

Country Status (16)

Country	Link
EP (1)	EP1644393A2 (no)
JP (1)	JP2007516172A (no)
KR (1)	KR20060091050A (no)
AU (1)	AU2004261550A1 (no)
BR (1)	BRPI0411534A (no)
CA (1)	CA2528592A1 (no)
EC (1)	ECSP056233A (no)
GE (1)	GEP20084437B (no)
IL (1)	IL172183A0 (no)
IS (1)	IS8147A (no)
MA (1)	MA27860A1 (no)
MX (1)	MXPA05013915A (no)
NO (1)	NO20055893L (no)
OA (1)	OA13179A (no)
RS (1)	RS20050931A (no)
WO (1)	WO2005012320A2 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ538141A (en)	2002-08-15	2007-06-29	Vicuron Pharm Inc	Lincomycin derivatives possessing antibacterial activity
US7199105B2 (en)	2002-08-15	2007-04-03	Vicuron Pharmaceuticals, Inc.	Lincomycin derivatives possessing antibacterial activity
US7256177B2 (en)	2003-06-17	2007-08-14	Vicuron Pharmaceuticals, Inc.	Lincomycin derivatives possessing antibacterial activity
US7199106B2 (en)	2003-06-17	2007-04-03	Vicuron Pharmaceuticals, Inc.	Lincomycin derivatives possessing antimicrobial activity
CA2528596A1 (en) *	2003-06-17	2005-01-27	Vicuron Pharmaceuticals Inc.	Lincomycin derivatives possessing antibacterial activity
US7361743B2 (en) *	2004-02-11	2008-04-22	Pfizer Inc	Lincomycin derivatives possessing antibacterial activity
BRPI0615300A2 (pt) *	2005-08-31	2009-07-14	Wyeth Corp	composto; composição farmacêutica; método para a preparação, tratamento ou controle de infecções bacterianas em animais de sangue quente; uso de um composto; e método para a preparação de compostos representados pela fórmula (i)
EP1970377A4 (en)	2005-12-09	2013-02-27	Meiji Seika Kaisha	LINCOMYCIN DERIVATIVE AND ANTIBACTERIAL AGENT CONTAINING THIS AS AN ACTIVE SUBSTANCE
US7879808B2 (en)	2007-05-31	2011-02-01	Meiji Seika Kaisha, Ltd.	Lincomycin derivatives and antimicrobial agents comprising the same as active ingredient
US7867980B2 (en)	2007-05-31	2011-01-11	Meiji Seika Kaisha, Ltd.	Lincosamide derivatives and antimicrobial agents comprising the same as active ingredient
US20130267699A1 (en)	2011-06-24	2013-10-10	California Institute Of Technology	Quaternary heteroatom containing compounds
US8822679B2 (en) *	2011-06-24	2014-09-02	California Institute Of Technology	Quaternary heteroatom containing compounds
US10421696B2 (en)	2014-12-18	2019-09-24	California Institute Of Technology	Enantioselective synthesis of α-quaternary mannich adducts by palladium-catalyzed allylic alkylation
CN107922373A (zh)	2015-03-27	2018-04-17	加利福尼亚技术学院	使用低催化剂浓度和稳定的预催化剂的不对称催化脱羧烷基烷基化
WO2017156239A1 (en)	2016-03-11	2017-09-14	California Institute Of Technology	Compositions and methods for acylating lactams
US10358422B2 (en)	2017-11-01	2019-07-23	California Institute Of Technology	Methods for enantioselective allylic alkylation of esters, lactones, and lactams with unactivated allylic alcohols
US11214568B2 (en)	2018-10-18	2022-01-04	California Institute Of Technology	Gem-disubstituted pyrrolidines, piperazines, and diazepanes, and compositions and methods of making the same
CN110357839A (zh) *	2019-08-29	2019-10-22	重庆经致制药技术开发有限公司	布瓦西坦手性中间体的制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL128232C (no) *	1964-04-13
US3268556A (en) *	1964-04-13	1966-08-23	Upjohn Co	Novel lincomycin derivatives
NL146501C (no) *	1964-07-01
US3282917A (en) *	1964-08-17	1966-11-01	Upjohn Co	Methyl n-(1-alkyl-4-alkoxy-prolyl)-alpha-thiolincosaminide compounds and process therefor
US3496163A (en) *	1965-02-08	1970-02-17	Upjohn Co	7-halo-7-deoxylincomycins and process for preparing the same
NL140527B (nl) *	1965-02-08	1973-12-17	Upjohn Co	Werkwijze ter bereiding van aan lincomycine verwante verbindingen.
US3555007A (en) *	1968-07-22	1971-01-12	Upjohn Co	7-deoxy-7-halo lincomycin d derivatives
US3549615A (en) *	1968-10-17	1970-12-22	Upjohn Co	Lincomycin derivatives and process for producing the same
DE2118636A1 (de) *	1970-04-20	1971-11-04	The Upjohn Co., Kalamazoo, Mich. (V.StA.)	3-Nucleotide von Lincomycin und deren Analogen, Verfahren zu ihrer Herstellung und ihre Verwendung in therapeutischen Präparaten
US3787390A (en) *	1971-06-23	1974-01-22	Upjohn Co	Analogs of lincomycin and process
US3849396A (en) *	1973-01-08	1974-11-19	Upjohn Co	Lincomycin and clindamycin 1-o-ethers
US3923602A (en) *	1973-10-25	1975-12-02	Upjohn Co	Composition of matter and process
JPS5641239A (en) *	1979-09-13	1981-04-17	Hitachi Cable Ltd	Flame-retardant composition
US4278789A (en) *	1979-11-23	1981-07-14	The Upjohn Company	Lincomycin compounds
NZ538141A (en) *	2002-08-15	2007-06-29	Vicuron Pharm Inc	Lincomycin derivatives possessing antibacterial activity
BRPI0411537A (pt) *	2003-06-17	2006-08-01	Vicuron Pharm Inc	derivados de lincomicina que possuem atividade antibacteriana

2004
- 2004-06-17 CA CA002528592A patent/CA2528592A1/en not_active Abandoned
- 2004-06-17 WO PCT/US2004/019689 patent/WO2005012320A2/en not_active Ceased
- 2004-06-17 KR KR1020057024291A patent/KR20060091050A/ko not_active Ceased
- 2004-06-17 JP JP2006517464A patent/JP2007516172A/ja active Pending
- 2004-06-17 BR BRPI0411534-1A patent/BRPI0411534A/pt not_active IP Right Cessation
- 2004-06-17 RS YUP-2005/0931A patent/RS20050931A/sr unknown
- 2004-06-17 MX MXPA05013915A patent/MXPA05013915A/es unknown
- 2004-06-17 GE GEAP20049117A patent/GEP20084437B/en unknown
- 2004-06-17 OA OA1200500364A patent/OA13179A/en unknown
- 2004-06-17 EP EP04776816A patent/EP1644393A2/en not_active Withdrawn
- 2004-06-17 AU AU2004261550A patent/AU2004261550A1/en not_active Abandoned
2005
- 2005-11-24 IS IS8147A patent/IS8147A/is unknown
- 2005-11-24 IL IL172183A patent/IL172183A0/en unknown
- 2005-12-12 NO NO20055893A patent/NO20055893L/no not_active Application Discontinuation
- 2005-12-16 EC EC2005006233A patent/ECSP056233A/es unknown
- 2005-12-16 MA MA28672A patent/MA27860A1/fr unknown

Also Published As

Publication number	Publication date
BRPI0411534A (pt)	2006-08-22
NO20055893L (no)	2006-03-14
IS8147A (is)	2005-11-24
WO2005012320A2 (en)	2005-02-10
IL172183A0 (en)	2011-08-01
JP2007516172A (ja)	2007-06-21
AU2004261550A1 (en)	2005-02-10
RS20050931A (sr)	2008-04-04
MA27860A1 (fr)	2006-04-03
HK1090061A1 (zh)	2006-12-15
CA2528592A1 (en)	2005-02-10
KR20060091050A (ko)	2006-08-17
MXPA05013915A (es)	2006-07-03
WO2005012320A3 (en)	2005-10-20
GEP20084437B (en)	2008-07-25
EP1644393A2 (en)	2006-04-12
ECSP056233A (es)	2006-04-19

Publication	Publication Date	Title
WO2005012320A2 (en)	2005-02-10	Novel lincomycin derivatives possessing antimicrobial activity
US7361743B2 (en)	2008-04-22	Lincomycin derivatives possessing antibacterial activity
KR100976063B1 (ko)	2010-08-17	신규한 벤즈아미드 유도체 화합물 및 그의 제조방법
AU2003265475B2 (en)	2009-08-27	Lincomycin derivatives possessing antibacterial activity
TW201247693A (en)	2012-12-01	C-4" position substituted macrolide derivative
EP3097103B1 (en)	2017-11-15	Diazabicyclo[4.3.1]decane derivatives for treatment of psychiatric disorders
EP1710248A1 (en)	2006-10-11	Novel aminoglycoside antibiotic effective against methicillin resistant staphylococcus aureus (mrsa)
US20040230046A1 (en)	2004-11-18	Lincomycin derivatives possessing antibacterial activity
US20050043248A1 (en)	2005-02-24	Novel lincomycin derivatives possessing antimicrobial activity
US7256177B2 (en)	2007-08-14	Lincomycin derivatives possessing antibacterial activity
WO2005007665A2 (en)	2005-01-27	Lincomycin derivatives possessing antibacterial activity
JP5356223B2 (ja)	2013-12-04	リンコマイシン誘導体及びこれを有効成分とする抗菌剤
WO1993019059A1 (en)	1993-09-30	Antiviral peptides
WO2007037518A9 (ja)	2007-05-31	ムチリン誘導体及びそれを含有する医薬組成物
HK1090061B (en)	2010-09-30	Novel lincomycin derivatives possessing antimicrobial activity
CN1823083B (zh)	2010-05-26	具备抗微生物活性的林可霉素衍生物
MXPA05014064A (en)	2006-10-17	Lincomycin derivatives possessing antibacterial activity
KR20090099594A (ko)	2009-09-22	항균 활성을 갖는 신규 린코마이신 유도체
JP2007528360A (ja)	2007-10-11	抗菌活性を有するリンコマイシン誘導体